Busca un médico

Andre Terzic, M.D., Ph.D.

Solicite una Consulta

Publicaciones

  1. Garmany A, Terzic A. Global Healthspan-Lifespan Gaps Among 183 World Health Organization Member States. JAMA Netw Open. 2024 Dec 2; 7 (12):e2450241 Epub 2024 Dec 02
    View PubMed
  2. Garmany A, Terzic A. Artificial intelligence powers regenerative medicine into predictive realm. Regen Med. 2024 Dec; 19 (12):611-616 Epub 2024 Dec 11
    View PubMed
  3. Garmany A, Arrell DK, Yamada S, Jeon R, Behfar A, Park S, Terzic A. Decoded cardiopoietic cell secretome linkage to heart repair biosignature. Stem Cells Transl Med. 2024 Nov 12; 13 (11):1144-1159
    View PubMed
  4. Livia C, Inglis S, Crespo-Diaz R, Rizzo S, Mahlberg R, Bagwell M, Hillestad M, Yamada S, Meenakshi Siddharthan DV, Singh RD, Li X, Arrell DK, Stalboerger P, Witt T, El Sabbagh A, Rihal M, Rihal C, Terzic A, Bartunek J, Behfar A. Infliximab Limits Injury in Myocardial Infarction. J Am Heart Assoc. 2024 May 7; 13 (9):e032172 Epub 2024 May 03
    View PubMed
  5. Gaihre B, Potes MDA, Liu X, Tilton M, Camilleri E, Rezaei A, Serdiuk V, Park S, Lucien F, Terzic A, Lu L. Extrusion 3D-printing and characterization of poly(caprolactone fumarate) for bone regeneration applications. J Biomed Mater Res A. 2024 May; 112 (5):672-684 Epub 2023 Nov 16
    View PubMed
  6. Yamada S, Bartunek J, Povsic TJ, Cotter G, Davison BA, Edwards C, Behfar A, Metra M, Filippatos GS, Vanderheyden M, Wijns W, Terzic A. Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial. Stem Cells Transl Med. 2024 Feb 14; 13 (2):116-124
    View PubMed
  7. Beetler DJ, Bruno KA, Watkins MM, Xu V, Chekuri I, Giresi P, Di Florio DN, Whelan ER, Edenfield BH, Walker SA, Morales-Lara AC, Hill AR, Jain A, Auda ME, Macomb LP, Shapiro KA, Keegan KC, Wolfram J, Behfar A, Stalboerger PG, Terzic A, Farres H, Cooper LT, Fairweather D. Reconstituted Extracellular Vesicles from Human Platelets Decrease Viral Myocarditis in Mice. Small. 2023 Dec; 19 (49):e2303317 Epub 2023 Aug 23
    View PubMed
  8. Bartunek J, Terzic A. Optimized Catheter System Demonstrates Utility for Endomyocardial Delivery of Cardiopoietic Stem Cells in Target Patients With Heart Failure. Tex Heart Inst J. 2023 Oct 23; 50 (5)
    View PubMed
  9. Liu X, Gaihre B, Park S, Li L, Dashtdar B, Astudillo Potes MD, Terzic A, Elder BD, Lu L. 3D-printed scaffolds with 2D hetero-nanostructures and immunomodulatory cytokines provide pro-healing microenvironment for enhanced bone regeneration. Bioact Mater. 2023 Sep; 27:216-230 Epub 2023 Apr 13
    View PubMed
  10. Holmuhamedov EL, Chakraborty P, Oberlin A, Liu X, Yousufuddin M, Shen WK, Terzic A, Jahangir A. Aging-associated susceptibility to stress-induced ventricular arrhythmogenesis is attenuated by tetrodotoxin. Biochem Biophys Res Commun. 2022 Oct 1; 623:44-50 Epub 2022 July 15
    View PubMed
  11. Xu H, Liu X, Park S, Terzic A, Lu L. Size-dependent osteogenesis of black phosphorus in nanocomposite hydrogel scaffolds. J Biomed Mater Res A. 2022 Aug; 110 (8):1488-1498 Epub 2022 Mar 23
    View PubMed
  12. Arrell DK, Park S, Yamada S, Alekseev AE, Garmany A, Jeon R, Vuckovic I, Lindor JZ, Terzic A. K(ATP) channel dependent heart multiome atlas. Sci Rep. 2022 May 5; 12 (1):7314 Epub 2022 May 05
    View PubMed
  13. Olesen K, Moruzzi N, Bulatovic I, Folmes C, Jeon R, Felldin U, Terzic A, Simonson OE, Le Blanc K, Osterholm C, Berggren PO, Schiffer T, Rodin S, Tilevik A, Grinnemo KH. Diversity of respiratory parameters and metabolic adaptation to low oxygen tension in mesenchymal stromal cells. Metabol Open. 2022 Mar; 13:100167 Epub 2022 Feb 03
    View PubMed
  14. Liu X, Li L, Gaihre B, Park S, Li Y, Terzic A, Elder BD, Lu L. Scaffold-Free Spheroids with Two-Dimensional Heteronano-Layers (2DHNL) Enabling Stem Cell and Osteogenic Factor Codelivery for Bone Repair. ACS Nano. 2022 Feb 22; 16 (2):2741-2755 Epub 2022 Jan 24
    View PubMed
  15. Klepinin A, Miller S, Reile I, Puurand M, Rebane-Klemm E, Klepinina L, Vija H, Zhang S, Terzic A, Dzeja P, Kaambre T. Stable Isotope Tracing Uncovers Reduced gamma/beta-ATP Turnover and Metabolic Flux Through Mitochondrial-Linked Phosphotransfer Circuits in Aggressive Breast Cancer Cells. Front Oncol. 2022; 12:892195 Epub 2022 May 31
    View PubMed
  16. Houdek MT, Wyles CC, Smith JH, Terzic A, Behfar A, Sierra RJ. Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head : mid-term update from a prospective study. Bone Jt Open. 2021 Nov; 2 (11):926-931
    View PubMed
  17. Yamada S, Bartunek J, Behfar A, Terzic A. Mass Customized Outlook for Regenerative Heart Failure Care. Int J Mol Sci. 2021 Oct 22; 22 (21)
    View PubMed
  18. Garmany A, Yamada S, Terzic A. Longevity leap: mind the healthspan gap. NPJ Regen Med. 2021 Sep 23; 6 (1):57 Epub 2021 Sept 23
    View PubMed
  19. Liu X, Camilleri ET, Li L, Gaihre B, Rezaei A, Park S, Miller Ii AL, Tilton M, Waletzki BE, Terzic A, Elder BD, Yaszemski MJ, Lu L. Injectable catalyst-free "click" organic-inorganic nanohybrid (click-ON) cement for minimally invasive in vivo bone repair. Biomaterials. 2021 Sep; 276:121014 Epub 2021 July 06
    View PubMed
  20. Arrell DK, Crespo-Diaz RJ, Yamada S, Jeon R, Garmany A, Park S, Adolf JP, Livia C, Hillestad ML, Bartunek J, Behfar A, Terzic A. Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome. Stem Cells Transl Med. 2021 Sep; 10 (9):1320-1328 Epub 2021 May 28
    View PubMed
  21. Xu H, Liu X, George MN, Miller AL 2nd, Park S, Xu H, Terzic A, Lu L. Black phosphorus incorporation modulates nanocomposite hydrogel properties and subsequent MC3T3 cell attachment, proliferation, and differentiation. J Biomed Mater Res A. 2021 Sep; 109 (9):1633-1645 Epub 2021 Mar 02
    View PubMed
  22. Sahre MD, Milligan L, Madabushi R, Graham RA, Reynolds KS, Terzic A, Benjamin J, Burckart GJ, Huang SM, Schuck R, Thompson AM, Zineh I. Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting. Clin Pharmacol Ther. 2021 Aug; 110 (2):285-288 Epub 2021 Feb 16
    View PubMed
  23. Yamada S, Jeon R, Garmany A, Behfar A, Terzic A. Screening for regenerative therapy responders in heart failure. Biomark Med. 2021 Jun; 15 (10):775-783 Epub 2021 June 25
    View PubMed
  24. Eylem CC, Baysal I, Erikci A, Yabanoglu-Ciftci S, Zhang S, Kir S, Terzic A, Dzeja P, Nemutlu E. Gas chromatography-mass spectrometry based (18)O stable isotope labeling of Krebs cycle intermediates. Anal Chim Acta. 2021 Apr 15; 1154:338325 Epub 2021 Feb 16
    View PubMed
  25. Zhang S, Yamada S, Park S, Klepinin A, Kaambre T, Terzic A, Dzeja P. Adenylate kinase AK2 isoform integral in embryo and adult heart homeostasis. Biochem Biophys Res Commun. 2021 Mar 26; 546:59-64 Epub 2021 Feb 08
    View PubMed
  26. Webster A, Terzic A. Regenerative readiness: innovation meets sociology. Regen Med. 2021 Mar; 16 (3):189-195 Epub 2021 Mar 30
    View PubMed
  27. Yamada S, Behfar A, Terzic A. Regenerative medicine clinical readiness. Regen Med. 2021 Mar; 16 (3):309-322 Epub 2021 Feb 24
    View PubMed
  28. Wyles SP, Monie DD, Paradise CR, Meyer FB, Hayden RE, Terzic A. Emerging workforce readiness in regenerative healthcare. Regen Med. 2021 Mar; 16 (3):197-206 Epub 2021 Feb 24
    View PubMed
  29. Li M, Yamada S, Shi A, Singh RD, Rolland TJ, Jeon R, Lopez N, Shelerud L, Terzic A, Behfar A. Brachyury engineers cardiac repair competent stem cells. Stem Cells Transl Med. 2021 Mar; 10 (3):385-397 Epub 2020 Oct 24
    View PubMed
  30. Sun Y, Liu X, George MN, Park S, Gaihre B, Terzic A, Lu L. Enhanced nerve cell proliferation and differentiation on electrically conductive scaffolds embedded with graphene and carbon nanotubes. J Biomed Mater Res A. 2021 Feb; 109 (2):193-206 Epub 2020 July 28
    View PubMed
  31. Li L, Liu X, Gaihre B, Park S, Li Y, Terzic A, Lu L. SDF-1alpha/OPF/BP Composites Enhance the Migrating and Osteogenic Abilities of Mesenchymal Stem Cells. Stem Cells Int. 2021; 2021:1938819 Epub 2021 Aug 13
    View PubMed
  32. Shi A, Li J, Qiu X, Sabbah M, Boroumand S, Huang TC, Zhao C, Terzic A, Behfar A, Moran SL. TGF-beta loaded exosome enhances ischemic wound healing in vitro and in vivo. Theranostics. 2021; 11 (13):6616-6631 Epub 2021 Apr 30
    View PubMed
  33. Houdek MT, Wyles CC, Smith JRH, Terzic A, Behfar A, Sierra RJ. Hip decompression combined with bone marrow concentrate and plateletrich plasma for corticosteroid-induced osteonecrosis of the femoral head. Bone and Joint Open. 2021; 2 (11):926-31
  34. Master Z, Crowley AP, Smith C, Wigle D, Terzic A, Sharp RR. Stem cell preservation for regenerative therapies: ethical and governance considerations for the health care sector. NPJ Regen Med. 2020 Dec 1; 5 (1):23 Epub 2020 Dec 01
    View PubMed
  35. Bartunek J, Terzic A, Davison BA, Behfar A, Sanz-Ruiz R, Wojakowski W, Sherman W, Heyndrickx GR, Metra M, Filippatos GS, Waldman SA, Teerlink JR, Henry TD, Gersh BJ, Hajjar R, Tendera M, Senger S, Cotter G, Povsic TJ, Wijns W, CHART Program. Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes. ESC Heart Fail. 2020 Dec; 7 (6):3345-3354 Epub 2020 Oct 23
    View PubMed
  36. Bansal A, Pandey MK, Yamada S, Goyal R, Schmit NR, Jeon R, Nesbitt JJ, Witt TA, Singh RD, Gunderson TM, Boroumand S, Li M, Crespo-Diaz RJ, Hillestad ML, Terzic A, Behfar A, DeGrado TR. [(89)Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure. Nucl Med Biol. 2020 Nov-Dec; 90-91:23-30 Epub 2020 Sept 09
    View PubMed
  37. Theis JL, Vogler G, Missinato MA, Li X, Nielsen T, Zeng XI, Martinez-Fernandez A, Walls SM, Kervadec A, Kezos JN, Birker K, Evans JM, O'Byrne MM, Fogarty ZC, Terzic A, Grossfeld P, Ocorr K, Nelson TJ, Olson TM, Colas AR, Bodmer R. Patient-specific genomics and cross-species functional analysis implicate LRP2 in hypoplastic left heart syndrome. Elife. 2020 Oct 2; 9 Epub 2020 Oct 02
    View PubMed
  38. Frljak S, Poglajen G, Zemljic G, Cerar A, Haddad F, Terzic A, Vrtovec B. Larger End-Diastolic Volume Associates With Response to Cell Therapy in Patients With Nonischemic Dilated Cardiomyopathy. Mayo Clin Proc. 2020 Oct; 95 (10):2125-2133
    View PubMed
  39. Warring SK, Novoa V, Shazly S, Trinidad MC, Sas DJ, Schiltz B, Prieto M, Terzic A, Ruano R. Serial Amnioinfusion as Regenerative Therapy for Pulmonary Hypoplasia in Fetuses With Intrauterine Renal Failure or Severe Renal Anomalies: Systematic Review and Future Perspectives. Mayo Clin Proc Innov Qual Outcomes. 2020 Aug; 4 (4):391-409 Epub 2020 Aug 05
    View PubMed
  40. Liu X, George MN, Park S, Miller Ii AL, Gaihre B, Li L, Waletzki BE, Terzic A, Yaszemski MJ, Lu L. 3D-printed scaffolds with carbon nanotubes for bone tissue engineering: Fast and homogeneous one-step functionalization. Acta Biomater. 2020 Jul 15; 111:129-140 Epub 2020 May 16
    View PubMed
  41. Manrique OJ, Bustos SS, Mohan AT, Nguyen MD, Martinez-Jorge J, Forte AJ, Terzic A. Robotic-Assisted DIEP Flap Harvest for Autologous Breast Reconstruction: A Comparative Feasibility Study on a Cadaveric Model. J Reconstr Microsurg. 2020 Jun; 36 (5):362-368 Epub 2020 Feb 27
    View PubMed
  42. Sterner RM, Hedin KE, Hayden RE, Nowakowski GS, Wyles SP, Greenberg-Worisek AJ, Terzic A, Kenderian SS. A Graduate-Level Interdisciplinary Curriculum in CAR-T Cell Therapy. Mayo Clin Proc Innov Qual Outcomes. 2020 Apr; 4 (2):203-210 Epub 2020 Mar 16
    View PubMed
  43. Ruano R, Daniels DJ, Ahn ES, Ibirogba ER, Lu VM, Snyder KA, Trinidad M, Carey WA, Colby CE, Kolbe AB, Arendt KW, Segura L, Sviggum HP, Qureshi MY, Famuyide A, Terzic A. In Utero Restoration of Hindbrain Herniation in Fetal Myelomeningocele as Part of Prenatal Regenerative Therapy Program at Mayo Clinic. Mayo Clin Proc. 2020 Apr; 95 (4):738-746
    View PubMed
  44. Manrique OJ, Bustos SS, Kapoor T, Lin J, Ciudad P, Forte AJ, Del Corral G, Mani M, Maruccia M, Terzic A. Gastroepiploic vascularized lymph node transfer for the treatment of extremity lymphedema: comparison between middle and distal inset. Gland Surg. 2020 Apr; 9 (2):528-538
    View PubMed
  45. Ma H, Hayama T, Van Dyken C, Darby H, Koski A, Lee Y, Gutierrez NM, Yamada S, Li Y, Andrews M, Ahmed R, Liang D, Gonmanee T, Kang E, Nasser M, Kempton B, Brigande J, McGill TJ, Terzic A, Amato P, Mitalipov S. Deleterious mtDNA mutations are common in mature oocytes. Biol Reprod. 2020 Mar 13; 102 (3):607-619
    View PubMed
  46. Arrell DK, Rosenow CS, Yamada S, Behfar A, Terzic A. Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome. NPJ Regen Med. 2020 Mar 12; 5 (1):5
    View PubMed
  47. Bydon M, Dietz AB, Goncalves S, Moinuddin FM, Alvi MA, Goyal A, Yolcu Y, Hunt CL, Garlanger KL, Del Fabro AS, Reeves RK, Terzic A, Windebank AJ, Qu W. CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury. Mayo Clin Proc. 2020 Feb; 95 (2):406-414 Epub 2019 Nov 27
    View PubMed
  48. Yamada S, Arrell DK, Rosenow CS, Bartunek J, Behfar A, Terzic A. Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy. Stem Cells Transl Med. 2020 Jan; 9 (1):74-79 Epub 2019 Aug 02
    View PubMed
  49. Arrell DK, Rosenow CS, Yamada S, Behfar A, Terzic A. Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome. NPJ Regen Med. 2020; 5:5 Epub 2020 Mar 12
    View PubMed
  50. Klepinin A, Zhang S, Klepinina L, Rebane-Klemm E, Terzic A, Kaambre T, Dzeja P. Adenylate Kinase and Metabolic Signaling in Cancer Cells. Front Oncol. 2020; 10:660 Epub 2020 May 19
    View PubMed
  51. Yamada S, Terzic A. Path Toward Proactive Therapy for Patent Ductus Arteriosus. Clin Pharmacol Ther. 2019 Dec; 106 (6):1187-1190 Epub 2019 Aug 21
    View PubMed
  52. Chlan LL, Tofthagen C, Terzic A. The Regenerative Horizon: Opportunities for Nursing Research and Practice. J Nurs Scholarsh. 2019 Nov; 51(6):651-660. Epub 2019 Sep 30.
    View PubMed
  53. Zhu Y, Tonne JM, Liu Q, Schreiber CA, Zhou Z, Rakshit K, Matveyenko AV, Terzic A, Wigle D, Kudva YC, Ikeda Y. Targeted Derivation of Organotypic Glucose- and GLP-1-Responsive beta Cells Prior to Transplantation into Diabetic Recipients. Stem Cell Reports. 2019 Aug 13; 13 (2):307-321 Epub 2019 Aug 01
    View PubMed
  54. Wyles CC, Paradise CR, Houdek MT, Slager SL, Terzic A, Behfar A, van Wijnen AJ, Sierra RJ. CORR(R) ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-gamma (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation. Clin Orthop Relat Res. 2019 Aug; 477 (8):1800-1812
    View PubMed
  55. Liu X, Miller AL 2nd, Park S, George MN, Waletzki BE, Xu H, Terzic A, Lu L. Two-Dimensional Black Phosphorus and Graphene Oxide Nanosheets Synergistically Enhance Cell Proliferation and Osteogenesis on 3D Printed Scaffolds. ACS Appl Mater Interfaces. 2019 Jul 3; 11 (26):23558-23572 Epub 2019 June 14
    View PubMed
  56. Wyles SP, Terzic A. Building the regenerative medicine workforce of the future: an educational imperative. Regen Med 2019 Jul; 14 (7):613-615 Epub 2019 July 25
    View PubMed
  57. Alekseev AE, Park S, Pimenov OY, Reyes S, Terzic A. Sarcolemmal alpha2-adrenoceptors in feedback control of myocardial response to sympathetic challenge. Pharmacol Ther. 2019 May; 197:179-190 Epub 2019 Jan 28
    View PubMed
  58. Neri T, Hiriart E, van Vliet PP, Faure E, Norris RA, Farhat B, Jagla B, Lefrancois J, Sugi Y, Moore-Morris T, Zaffran S, Faustino RS, Zambon AC, Desvignes JP, Salgado D, Levine RA, de la Pompa JL, Terzic A, Evans SM, Markwald R, Puceat M. Human pre-valvular endocardial cells derived from pluripotent stem cells recapitulate cardiac pathophysiological valvulogenesis. Nat Commun. 2019 Apr 26; 10 (1):1929
    View PubMed
  59. Behfar A, Terzic A. Regeneration for All: An Odyssey in Biotherapy. Eur Heart J. 2019 Apr 1; 40 (13):1033-1035
    View PubMed
  60. Li J, Liu X, Park S, Miller AL 2nd, Terzic A, Lu L. Strontium-substituted hydroxyapatite stimulates osteogenesis on poly(propylene fumarate) nanocomposite scaffolds. J Biomed Mater Res A. 2019 Mar; 107 (3):631-642 Epub 2018 Nov 25
    View PubMed
  61. Wyles SP, Hayden RE, Meyer FB, Terzic A. Regenerative medicine curriculum for next-generation physicians. NPJ Regen Med. 2019; 4:3 Epub 2019 Feb 07
    View PubMed
  62. Ruano R, Enninga EAL, Brana Rivera PE, Terzic A. Regenerative Prophylaxis In Utero. Clin Pharmacol Ther. 2019 Jan; 105 (1):39-41 Epub 2018 Nov 11
    View PubMed
  63. Singh RD, Hillestad ML, Livia C, Li M, Alekseev AE, Witt TA, Stalboerger PG, Yamada S, Terzic A, Behfar A. M(3)RNA Drives Targeted Gene Delivery in Acute Myocardial Infarction. Tissue Eng Part A. 2019 Jan; 25 (1-2):145-158 Epub 2018 Sept 21
    View PubMed
  64. Nath KA, O'Brien DR, Croatt AJ, Grande JP, Ackerman AW, Nath MC, Yamada S, Terzic A, Tchkonia T, Kirkland JL, Katusic ZS. The murine dialysis fistula model exhibits a senescence phenotype: pathobiological mechanisms and therapeutic potential. Am J Physiol Renal Physiol. 2018 Nov 1; 315 (5):F1493-F1499 Epub 2018 July 18
    View PubMed
  65. Zhou Z, Liu X, Wu W, Park S, Miller Ii AL, Terzic A, Lu L. Effective nerve cell modulation by electrical stimulation of carbon nanotube embedded conductive polymeric scaffolds. Biomater Sci. 2018 Aug 21; 6 (9):2375-2385
    View PubMed
  66. Ruano R, Klinkner DB, Balakrishnan K, Novoa Y Novoa VA, Davies N, Potter DD, Carey WA, Colby CE, Kolbe AB, Arendt KW, Segura L, Sviggum HP, Lemens MA, Famuyide A, Terzic A. Fetoscopic Therapy for Severe Pulmonary Hypoplasia in Congenital Diaphragmatic Hernia: A First in Prenatal Regenerative Medicine at Mayo Clinic. Mayo Clin Proc. 2018 Jun; 93 (6):693-700
    View PubMed
  67. Bartunek J, Terzic A, Behfar A, Wijns W. Clinical Experience With Regenerative Therapy in Heart Failure: Advancing Care With Cardiopoietic Stem Cell Interventions. Circ Res. 2018 May 11; 122 (10):1344-1346
    View PubMed
  68. Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, Sierra RJ. Reply to the Letter to the Editor: Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study. Clin Orthop Relat Res 2018 May; 476 (5):1129-1130
    View PubMed
  69. Hargraves IG, Behfar A, Foxen JL, Montori VM, Terzic A. Towards regeneration: the evolution of medicine from fighting to building. BMJ. 2018 Apr 17; 361:k1586
    View PubMed
  70. Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, Sierra RJ. Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study. Clin Orthop Relat Res. 2018 Feb; 476 (2):388-397
    View PubMed
  71. Saris DBF, de Windt TS, Vonk LA, Krych AJ, Terzic A. Regenerative Musculoskeletal Care: Ensuring Practice Implementation. Clin Pharmacol Ther. 2018 Jan; 103 (1):50-53 Epub 2017 Oct 16
    View PubMed
  72. Musunuru K, Sheikh F, Gupta RM, Houser SR, Maher KO, Milan DJ, Terzic A, Wu JC. Induced pluripotent stem cells for cardiovascular disease modeling and precision medicine a scientific statement from the American Heart Association Circulation-Cardiovascular Genetics. 2018 Jan; 11 (1):e000043
  73. Miyazaki T, Ishizaki M, Dohra H, Park S, Terzic A, Kato T, Kohsaka T, Park EY. Insulin-like peptide 3 expressed in the silkworm possesses intrinsic disulfide bonds and full biological activity. Sci Rep. 2017 Dec 11; 7 (1):17339
    View PubMed
  74. Park S, Arrell DK, Reyes S, Park EY, Terzic A. Conventional and unconventional secretory proteins expressed with silkworm bombyxin signal peptide display functional fidelity. Sci Rep. 2017 Nov 3; 7 (1):14499 Epub 2017 Nov 03
    View PubMed
  75. Teerlink JR, Metra M, Filippatos GS, Davison BA, Bartunek J, Terzic A, Gersh BJ, Povsic TJ, Henry TD, Alexandre B, Homsy C, Edwards C, Seron A, Wijns W, Cotter G, CHART Investigators. Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study. Eur J Heart Fail. 2017 Nov; 19 (11):1520-1529 Epub 2017 May 31
    View PubMed
  76. Fernandez-Aviles F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Luscher TF, Martin JF, Menasche P, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC, TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) Writing Group//Authors/Task Force Members. Chairpersons//Basic Research Subcommittee//Translational Research Subcommittee//Challenges of Cardiovascular Regenerative Medicine Subcommittee//Tissue Engineering Sub. Global position paper on cardiovascular regenerative medicine. Eur Heart J. 2017 Sep 1; 38 (33):2532-2546
    View PubMed
  77. Liu X, Miller AL 2nd, Park S, Waletzki BE, Zhou Z, Terzic A, Lu L. Functionalized Carbon Nanotube and Graphene Oxide Embedded Electrically Conductive Hydrogel Synergistically Stimulates Nerve Cell Differentiation. ACS Appl Mater Interfaces. 2017 May 3; 9 (17):14677-14690 Epub 2017 Apr 20
    View PubMed
  78. Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, Merkely B, Musialek P, Wojakowski W, Andreka P, Horvath IG, Katz A, Dolatabadi D, El Nakadi B, Arandjelovic A, Edes I, Seferovic PM, Obradovic S, Vanderheyden M, Jagic N, Petrov I, Atar S, Halabi M, Gelev VL, Shochat MK, Kasprzak JD, Sanz-Ruiz R, Heyndrickx GR, Nyolczas N, Legrand V, Guedes A, Heyse A, Moccetti T, Fernandez-Aviles F, Jimenez-Quevedo P, Bayes-Genis A, Hernandez-Garcia JM, Ribichini F, Gruchala M, Waldman SA, Teerlink JR, Gersh BJ, Povsic TJ, Henry TD, Metra M, Hajjar RJ, Tendera M, Behfar A, Alexandre B, Seron A, Stough WG, Sherman W, Cotter G, Wijns W, CHART Program. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. Eur Heart J. 2017 Mar 1; 38 (9):648-660
    View PubMed
  79. Waldman SA, Terzic A. Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum. Clin Pharmacol Ther 2017 Jan; 101 (1):8-12 Epub 2016 Nov 21
    View PubMed
  80. Nakipova OV, Averin AS, Evdokimovskii EV, Pimenov OY, Kosarski L, Ignat'ev D, Anufriev A, Kokoz YM, Reyes S, Terzic A, Alekseev AE. Store-operated Ca2+ entry supports contractile function in hearts of hibernators. PLoS One. 2017; 12 (5):e0177469 Epub 2017 May 22
    View PubMed
  81. Liu X, Miller II AL, Park S, Waletzki BE, Terzic A, Yaszemski MJ, Lu L. Covalent crosslinking of graphene oxide and carbon nanotube into hydrogels enhances nerve cell responses. J Mater Chem B. 2016 Nov 21; 4 (43):6930-6941 Epub 2016 Sept 20
    View PubMed
  82. Perales-Clemente E, Cook AN, Evans JM, Roellinger S, Secreto F, Emmanuele V, Oglesbee D, Mootha VK, Hirano M, Schon EA, Terzic A, Nelson TJ. Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability. EMBO J. 2016 Sep 15; 35 (18):1979-90 Epub 2016 July 19
    View PubMed
  83. Terzic A, Behfar A. Stem cell therapy for heart failure: Ensuring regenerative proficiency. Trends Cardiovasc Med. 2016 Jul; 26 (5):395-404 Epub 2016 Jan 28
    View PubMed
  84. Folmes CD, Ma H, Mitalipov S, Terzic A. Mitochondria in pluripotent stem cells: stemness regulators and disease targets. Curr Opin Genet Dev. 2016 Jun; 38:1-7 Epub 2016 Mar 05
    View PubMed
  85. Wyles SP, Hrstka SC, Reyes S, Terzic A, Olson TM, Nelson TJ. Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model. Clin Transl Sci. 2016 Jun; 9 (3):158-67 Epub 2016 Apr 22
    View PubMed
  86. Kang E, Wang X, Tippner-Hedges R, Ma H, Folmes CD, Gutierrez NM, Lee Y, Van Dyken C, Ahmed R, Li Y, Koski A, Hayama T, Luo S, Harding CO, Amato P, Jensen J, Battaglia D, Lee D, Wu D, Terzic A, Wolf DP, Huang T, Mitalipov S. Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs. Cell Stem Cell. 2016 May 5; 18 (5):625-36 Epub 2016 Apr 14
    View PubMed
  87. El Khatib MM, Ohmine S, Jacobus EJ, Tonne JM, Morsy SG, Holditch SJ, Schreiber CA, Uetsuka K, Fusaki N, Wigle DA, Terzic A, Kudva YC, Ikeda Y. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration. Stem Cells Transl Med. 2016 May; 5 (5):694-702 Epub 2016 Mar 17
    View PubMed
  88. Houdek MT, Wyles CC, Stalboerger PG, Terzic A, Behfar A, Moran SL. Collagen and Fractionated Platelet-Rich Plasma Scaffold for Dermal Regeneration. Plast Reconstr Surg. 2016 May; 137 (5):1498-1506
    View PubMed
  89. Folmes CD, Terzic A. Energy metabolism in the acquisition and maintenance of stemness. Semin Cell Dev Biol. 2016 Apr; 52:68-75 Epub 2016 Feb 08
    View PubMed
  90. Houdek MT, Wyles CC, Packard BD, Terzic A, Behfar A, Sierra RJ. Decreased Osteogenic Activity of Mesenchymal Stem Cells in Patients With Corticosteroid-Induced Osteonecrosis of the Femoral Head. J Arthroplasty. 2016 Apr; 31 (4):893-8 Epub 2015 Aug 29
    View PubMed
  91. Faustino RS, Behfar A, Groenendyk J, Wyles SP, Niederlander N, Reyes S, Puceat M, Michalak M, Terzic A, Perez-Terzic C. Calreticulin secures calcium-dependent nuclear pore competency required for cardiogenesis. J Mol Cell Cardiol. 2016 Mar; 92:63-74 Epub 2016 Jan 27
    View PubMed
  92. Li X, Campbell KA, Biendarra SM, Terzic A, Nelson TJ. Mapping transcriptome profiles of in vitro iPSC-derived cardiac differentiation to in utero heart development. Genom Data. 2016 Mar; 7:129-30 Epub 2015 Dec 30
    View PubMed
  93. Bartunek J, Davison B, Sherman W, Povsic T, Henry TD, Gersh B, Metra M, Filippatos G, Hajjar R, Behfar A, Homsy C, Cotter G, Wijns W, Tendera M, Terzic A. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design. Eur J Heart Fail. 2016 Feb; 18 (2):160-8 Epub 2015 Dec 14
    View PubMed
  94. Wyles SP, Li X, Hrstka SC, Reyes S, Oommen S, Beraldi R, Edwards J, Terzic A, Olson TM, Nelson TJ. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells. Hum Mol Genet. 2016 Jan 15; 25 (2):254-65 Epub 2015 Nov 24
    View PubMed
  95. Ryan ZC, Craig TA, Folmes CD, Wang X, Lanza IR, Schaible NS, Salisbury JL, Nair KS, Terzic A, Sieck GC, Kumar R. 1alpha,25-Dihydroxyvitamin D3 Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells. J Biol Chem. 2016 Jan 15; 291 (3):1514-28 Epub 2015 Nov 24
    View PubMed
  96. Sanz-Ruiz R, Bolli R, Gersh BJ, Janssens S, Perin EC, Taylor DA, Terzic A, Willerson JT. The TACTICS initiative: time for a global alliance on cardiovascular regenerative medicine European Heart Journal. 2016; 37: (28)2208-11.
  97. Terzic A, Pfenning MA, Gores GJ, Harper CM Jr. Regenerative Medicine Build-Out. Stem Cells Transl Med. 2015 Dec; 4 (12):1373-9 Epub 2015 Nov 04
    View PubMed
  98. Hwang IW, Makishima Y, Suzuki T, Kato T, Park S, Terzic A, Chung SK, Park EY. Phosphorylation of Ser-204 and Tyr-405 in human malonyl-CoA decarboxylase expressed in silkworm Bombyx mori regulates catalytic decarboxylase activity. Appl Microbiol Biotechnol. 2015 Nov; 99: (21)8977-86.
    View PubMed
  99. Campbell KA, Li X, Biendarra SM, Terzic A, Nelson TJ. Nos3-/- iPSCs model concordant signatures of in utero cardiac pathogenesis. J Mol Cell Cardiol. 2015 Oct; 87:228-36.
    View PubMed
  100. Wyles CC, Houdek MT, Crespo-Diaz RJ, Norambuena GA, Stalboerger PG, Terzic A, Behfar A, Sierra RJ. Adipose-derived Mesenchymal Stem Cells Are Phenotypically Superior for Regeneration in the Setting of Osteonecrosis of the Femoral Head. Clin Orthop Relat Res. 2015 Oct; 473 (10):3080-90 Epub 2015 June 13
    View PubMed
  101. Banovic M, Loncar Z, Behfar A, Vanderheyden M, Beleslin B, Zeiher A, Metra M, Terzic A, Bartunek J. Endpoints in stem cell trials in ischemic heart failure. Stem Cell Res Ther. 2015 Aug 29; 6 (1):159
    View PubMed
  102. O'Brien T, Creane M, Windebank AJ, Terzic A, Dietz AB. Translating stem cell research to the clinic: a primer on translational considerations for your first stem cell protocol. Stem Cell Res Ther. 2015 Aug 22; 6:146
    View PubMed
  103. Ma H, Folmes CD, Wu J, Morey R, Mora-Castilla S, Ocampo A, Ma L, Poulton J, Wang X, Ahmed R, Kang E, Lee Y, Hayama T, Li Y, Van Dyken C, Gutierrez NM, Tippner-Hedges R, Koski A, Mitalipov N, Amato P, Wolf DP, Huang T, Terzic A, Laurent LC, Izpisua Belmonte JC, Mitalipov S. Metabolic rescue in pluripotent cells from patients with mtDNA disease. Nature. 2015 Aug 13; 524 (7564):234-8 Epub 2015 July 15
    View PubMed
  104. Dalen M, Behfar A, Terzic A, Schiller P, Seron A, Sherman W, Mansson-Broberg A, Grinnemo KH. Percutaneous fluoroscopic-guided endomyocardial delivery in an experimental model of left ventricular assist device support. Journal Of Cardiovascular Translational Research. 2015 Aug; 8(6):381-4.
    View PubMed
  105. Faustino RS, Wyles SP, Groenendyk J, Michalak M, Terzic A, Perez-Terzic C. Systems biology surveillance decrypts pathological transcriptome remodeling. BMC Syst Biol. 2015 Jul 17; 9:36 Epub 2015 July 17
    View PubMed
  106. Cabral-Teixeira J, Martinez-Fernandez A, Cai W, Terzic A, Mercola M, Willems E. Cholesterol-derived glucocorticoids control early fate specification in embryonic stem cells. Stem Cell Res. 2015 Jul; 15 (1):88-95 Epub 2015 May 14
    View PubMed
  107. Nemutlu E, Zhang S, Xu YZ, Terzic A, Zhong L, Dzeja PD, Cha YM. Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure. J Card Fail. 2015 Jun; 21 (6):460-9 Epub 2015 Apr 22
    View PubMed
  108. Wang Y, Cao Y, Yamada S, Thirunavukkarasu M, Nin V, Joshi M, Rishi MT, Bhattacharya S, Camacho-Pereira J, Sharma AK, Shameer K, Kocher JP, Sanchez JA, Wang E, Hoeppner LH, Dutta SK, Leof EB, Shah V, Claffey KP, Chini EN, Simons M, Terzic A, Maulik N, Mukhopadhyay D. Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-alpha Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1alpha and Mitochondrial Homeostasis. Arterioscler Thromb Vasc Biol. 2015 Jun; 35 (6):1401-12 Epub 2015 Apr 16
    View PubMed
  109. Wyles SP, Faustino RS, Li X, Terzic A, Nelson TJ. Systems-based technologies in profiling the stem cell molecular framework for cardioregenerative medicine. Stem Cell Rev. 2015 Jun; 11: (3)501-10.
    View PubMed
  110. Yamada S, Arrell DK, Martinez-Fernandez A, Behfar A, Kane GC, Perez-Terzic CM, Crespo-Diaz RJ, McDonald RJ, Wyles SP, Zlatkovic-Lindor J, Nelson TJ, Terzic A. Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy. J Am Heart Assoc. 2015 May 11; 4 (5)
    View PubMed
  111. Vivaudou M, Terzic A. Antiobesity strategy targets energy economy safeguards. Mol Ther 2015 Apr; 23 (4):615-6
    View PubMed
  112. Oommen S, Yamada S, Cantero Peral S, Campbell KA, Bruinsma ES, Terzic A, Nelson TJ. Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload. Stem Cell Res Ther. 2015 Mar 26; 6:50
    View PubMed
  113. Cantero Peral S, Burkhart HM, Oommen S, Yamada S, Nyberg SL, Li X, O'Leary PW, Terzic A, Cannon BC, Nelson TJ, Wanek Program Porcine Pipeline Group. Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system. Stem Cells Transl Med. 2015 Feb; 4(2):195-206. Epub 2015 Jan 05.
    View PubMed
  114. Campbell KA, Terzic A, Nelson TJ. Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery. Regen Med. 2015; 10 (6):773-83 Epub 2015 Oct 06
    View PubMed
  115. Nemutlu E, Zhang S, Terzic A, Dzeja P. 18O-assisted 31P NMR and mass spectrometry for phosphometabolomic fingerprinting and metabolic monitoring. Issues in Toxicology. 2015; 2015-January(21):255-86.
  116. Nemutlu E, Gupta A, Zhang S, Viqar M, Holmuhamedov E, Terzic A, Jahangir A, Dzeja P. Decline of Phosphotransfer and Substrate Supply Metabolic Circuits Hinders ATP Cycling in Aging Myocardium. PLoS One. 2015; 10 (9):e0136556 Epub 2015 Sept 17
    View PubMed
  117. Farouz Y, Chen Y, Terzic A, Menasche P. Concise review: Growing hearts in the right place: On the design of biomimetic materials for cardiac stem cell differentiation. Stem Cells. 2015; 33(4):1021-35.
    View PubMed
  118. Waldman SA, Terzic A. Companion diagnostics at the intersection of personalized medicine and healthcare delivery. Biomark. Med. 2015; 9(1):1-3.
    View PubMed
  119. Bansal A, Pandey MK, Demirhan YE, Nesbitt JJ, Crespo-Diaz RJ, Terzic A, Behfar A, DeGrado TR. Novel (89)Zr cell labeling approach for PET-based cell trafficking studies. EJNMMI Res. 2015; 5:19 Epub 2015 Mar 28
    View PubMed
  120. Crespo-Diaz R, Yamada S, Bartunek J, Perez-Terzic C, de Waele P, Mauen S, Terzic A, Behfar A. Cardiopoietic index predicts heart repair fitness of patient-derived stem cells. Biomark Med. 2015; 9 (7):639-49 Epub 2015 May 27
    View PubMed
  121. Folmes CD, Terzic A. Metabolic determinants of embryonic development and stem cell fate. Reprod Fertil Dev. 2014 Dec; 27 (1):82-8
    View PubMed
  122. Behfar A, Terzic A, Perez-Terzic CM. Regenerative principles enrich cardiac rehabilitation practice. Am J Phys Med Rehabil. 2014 Nov; 93 (11 Suppl 3):S169-75
    View PubMed
  123. Perales-Clemente E, Folmes CD, Terzic A. Metabolic regulation of redox status in stem cells. Antioxid Redox Signal. 2014 Oct 10; 21 (11):1648-59 Epub 2014 Sept 04
    View PubMed
  124. Martinez-Fernandez A, Nelson TJ, Reyes S, Alekseev AE, Secreto F, Perez-Terzic C, Beraldi R, Sung HK, Nagy A, Terzic A. iPS cell-derived cardiogenicity is hindered by sustained integration of reprogramming transgenes. Circ Cardiovasc Genet. 2014 Oct; 7 (5):667-76 Epub 2014 July 30
    View PubMed
  125. Wyles SP, Yamada S, Oommen S, Maleszewski JJ, Beraldi R, Martinez-Fernandez A, Terzic A, Nelson TJ. Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy. Stem Cells Dev. 2014 Oct 1; 23 (19):2274-82 Epub 2014 Aug 21
    View PubMed
  126. Hwang IW, Makishima Y, Kato T, Park S, Terzic A, Park EY. Human acetyl-coa carboxylase 2 expressed in silkworm bombyx mori exhibits posttranslational biotinylation and phosphorylation. Appl Microbiol Biotechnol. 2014 Oct; 98(19):8201-9.
    View PubMed
  127. Suresh R, Li X, Chiriac A, Goel K, Terzic A, Perez-Terzic C, Nelson TJ. Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction. J Mol Cell Cardiol. 2014 Sep; 74:13-21 Epub 2014 May 04
    View PubMed
  128. Hartjes KA, Li X, Martinez-Fernandez A, Roemmich AJ, Larsen BT, Terzic A, Nelson TJ. Selection via pluripotency-related transcriptional screen minimizes the influence of somatic origin on iPSC differentiation propensity. Stem Cells. 2014 Sep; 32 (9):2350-9
    View PubMed
  129. Beraldi R, Li X, Martinez Fernandez A, Reyes S, Secreto F, Terzic A, Olson TM, Nelson TJ. Rbm20-deficient cardiogenesis reveals early disruption of RNA processing and sarcomere remodeling establishing a developmental etiology for dilated cardiomyopathy. Hum Mol Genet. 2014 Jul 15; 23 (14):3779-91 Epub 2014 Feb 28
    View PubMed
  130. Li X, Martinez-Fernandez A, Hartjes KA, Kocher JP, Olson TM, Terzic A, Nelson TJ. Transcriptional atlas of cardiogenesis maps congenital heart disease interactome. Physiol Genomics. 2014 Jul 1; 46 (13):482-95 Epub 2014 May 06
    View PubMed
  131. Holditch SJ, Terzic A, Ikeda Y. Concise review: pluripotent stem cell-based regenerative applications for failing beta-cell function. Stem Cells Transl Med. 2014 May; 3 (5):653-61 Epub 2014 Mar 19
    View PubMed
  132. Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ. Cell therapy for cardiac repair--lessons from clinical trials. Nat Rev Cardiol. 2014 Apr; 11 (4):232-46 Epub 2014 Mar 04
    View PubMed
  133. Nofziger C, Papaluca M, Terzic A, Waldman S, Paulmichl M. Policies to aid the adoption of personalized medicine. Nat Rev Drug Discov. 2014 Mar; 13 (3):159-60
    View PubMed
  134. Hu D, Barajas-Martinez H, Terzic A, Park S, Pfeiffer R, Burashnikov E, Wu Y, Borggrefe M, Veltmann C, Schimpf R, Cai JJ, Nam GB, Deshmukh P, Scheinman M, Preminger M, Steinberg J, Lopez-Izquierdo A, Ponce-Balbuena D, Wolpert C, Haissaguerre M, Sanchez-Chapula JA, Antzelevitch C. ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene. Int J Cardiol. 2014 Feb 15; 171 (3):431-42 Epub 2014 Jan 04
    View PubMed
  135. Barbato E, Lara-Pezzi E, Stolen C, Taylor A, Barton PJ, Bartunek J, Iaizzo P, Judge DP, Kirshenbaum L, Blaxall BC, Terzic A, Hall JL. Advances in induced pluripotent stem cells, genomics, biomarkers, and antiplatelet therapy highlights of the year in JCTR 2013. Journal of Cardiovascular Translational Research. 2014; 7(5):518-25.
    View PubMed
  136. Behfar A, Latere JP, Bartunek J, Homsy C, Daro D, Crespo-Diaz RJ, Stalboerger PG, Steenwinckel V, Seron A, Redfield MM, Terzic A. Optimized delivery system achieves enhanced endomyocardial stem cell retention. Cell Biol Int. 2014 Jan; 38(1):710-8.
  137. Yamada S, Arrell DK, Kane GC, Nelson TJ, Perez-Terzic CM, Behfar A, Purushothaman S, Prinzen FW, Auricchio A, Terzic A. Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K(+) channel-deficient dilated cardiomyopathy. J Am Heart Assoc. 2013 Dec 5; 2 (6):e000410 Epub 2013 Dec 05
    View PubMed
  138. Park S, Hwang IW, Makishima Y, Perales-Clemente E, Kato T, Niederlander NJ, Park EY, Terzic A. Spot14/Mig12 heterocomplex sequesters polymerization and restrains catalytic function of human acetyl-CoA carboxylase 2. J Mol Recognit. 2013 Dec; 26 (12):679-88
    View PubMed
  139. Terzic A, Harper CM Jr, Gores GJ, Pfenning MA. Regenerative medicine blueprint. Stem Cells Dev. 2013 Dec; 22 Suppl 1:20-4.
    View PubMed
  140. Behfar A, Latere JP, Bartunek J, Homsy C, Daro D, Crespo-Diaz RJ, Stalboerger PG, Steenwinckel V, Seron A, Redfield MM, Terzic A. Optimized delivery system achieves enhanced endomyocardial stem cell retention. Circ Cardiovasc Interv. 2013 Dec; 6 (6):710-8 Epub 2013 Dec 10
    View PubMed
  141. Suresh R, Chiriac A, Goel K, Villarraga HR, Lopez-Jimenez F, Thomas RJ, Terzic A, Nelson TJ, Perez-Terzic C. CXCR4+ and FLK-1+ identify circulating cells associated with improved cardiac function in patients following myocardial infarction. J Cardiovasc Transl Res. 2013 Oct; 6 (5):787-97 Epub 2013 Aug 10
    View PubMed
  142. Martinez-Fernandez A, Li X, Hartjes KA, Terzic A, Nelson TJ. Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines. Circ Cardiovasc Genet. 2013 Oct; 6 (5):462-71 Epub 2013 Sept 14
    View PubMed
  143. Yamada S, Nelson TJ, Kane GC, Martinez-Fernandez A, Crespo-Diaz RJ, Ikeda Y, Perez-Terzic C, Terzic A. Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction. J Physiol. 2013 Sep 1; 591 (17):4335-49 Epub 2013 Apr 08
    View PubMed
  144. Faustino RS, Arrell DK, Folmes CD, Terzic A, Perez-Terzic C. Stem cell systems informatics for advanced clinical biodiagnostics: tracing molecular signatures from bench to bedside. Croat Med J. 2013 Aug; 54 (4):319-29
    View PubMed
  145. Folmes CD, Arrell DK, Zlatkovic-Lindor J, Martinez-Fernandez A, Perez-Terzic C, Nelson TJ, Terzic A. Metabolome and metaboproteome remodeling in nuclear reprogramming. Cell Cycle. 2013 Aug 1; 12 (15):2355-65 Epub 2013 July 08
    View PubMed
  146. Folmes CD, Martinez-Fernandez A, Perales-Clemente E, Li X, McDonald A, Oglesbee D, Hrstka SC, Perez-Terzic C, Terzic A, Nelson TJ. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. Stem Cells. 2013 Jul; 31 (7):1298-308
    View PubMed
  147. Terzic A, Nelson TJ. Regenerative medicine primer. Mayo Clin Proc. 2013 Jul; 88 (7):766-75
    View PubMed
  148. Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, Tendera M, Waldman S, Wijns W, Terzic A. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol. 2013 Jun 11; 61(23):2329-38. Epub 2013 Apr 10.
    View PubMed
  149. Arrell DK, Terzic A. Interpreting networks in systems biology. Clin Pharmacol Ther. 2013 May; 93(5):389-92. Epub 2013 Feb 11.
    View PubMed
  150. Folmes CD, Martinez-Fernandez A, Faustino RS, Yamada S, Perez-Terzic C, Nelson TJ, Terzic A. Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells. J Cardiovasc Transl Res. 2013 Feb; 6 (1):10-21 Epub 2012 Dec 18
    View PubMed
  151. Waldman SA, Terzic A. Translational medicine individualizes healthcare discovery, development and delivery. Foreword. Biomark Med. 2013 Feb; 7(1):1-3.
    View PubMed
  152. Baker DJ, Dawlaty MM, Wijshake T, Jeganathan KB, Malureanu L, van Ree JH, Crespo-Diaz R, Reyes S, Seaburg L, Shapiro V, Behfar A, Terzic A, van de Sluis B, van Deursen JM. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2013 Jan; 15 (1):96-102 Epub 2012 Dec 16
    View PubMed
  153. Thatava T, Kudva YC, Edukulla R, Squillace K, De Lamo JG, Khan YK, Sakuma T, Ohmine S, Terzic A, Ikeda Y. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol Ther. 2013 Jan; 21 (1):228-39 Epub 2012 Nov 27
    View PubMed
  154. Waldman SA, van der Graaf PH, Terzic A. Systems approaches evolve clinical pharmacology. CPT Pharmacometrics Syst Pharmacol. 2013; 2:e68. Epub 2013 Aug 21.
    View PubMed
  155. Nemutlu E, Zhang S, Juranic NO, Terzic A, Macura S, Dzeja P. 18O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases. Croat Med J. 2012 Dec; 53 (6):529-34
    View PubMed
  156. Folmes CD, Dzeja PP, Nelson TJ, Terzic A. Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell. 2012 Nov 2; 11 (5):596-606
    View PubMed
  157. Strege P, Beyder A, Bernard C, Crespo-Diaz R, Behfar A, Terzic A, Ackerman M, Farrugia G. Ranolazine inhibits shear sensitivity of endogenous Na+ current and spontaneous action potentials in HL-1 cells. Channels (Austin). 2012 Nov-Dec; 6 (6):457-62 Epub 2012 Sept 27
    View PubMed
  158. Smith AJ, Nelson NG, Oommen S, Hartjes KA, Folmes CD, Terzic A, Nelson TJ. Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk. Stem Cells Transl Med. 2012 Oct; 1 (10):709-18 Epub 2012 Sept 27
    View PubMed
  159. Beyder A, Strege PR, Reyes S, Bernard CE, Terzic A, Makielski J, Ackerman MJ, Farrugia G. Ranolazine decreases mechanosensitivity of the voltage-gated sodium ion channel Na(v)1.5: a novel mechanism of drug action. Circulation. 2012 Jun 5; 125 (22):2698-706 Epub 2012 May 07
    View PubMed
  160. Nemutlu E, Juranic N, Zhang S, Ward LE, Dutta T, Nair KS, Terzic A, Macura S, Dzeja PP. Electron spray ionization mass spectrometry and 2D 31P NMR for monitoring 18O/16O isotope exchange and turnover rates of metabolic oligophosphates. Anal Bioanal Chem. 2012 May; 403 (3):697-706 Epub 2012 Mar 18
    View PubMed
  161. Nemutlu E, Zhang S, Gupta A, Juranic NO, Macura SI, Terzic A, Jahangir A, Dzeja P. Dynamic phosphometabolomic profiling of human tissues and transgenic models by 18O-assisted (3)(1)P NMR and mass spectrometry. Physiol Genomics. 2012 Apr 2; 44 (7):386-402 Epub 2012 Jan 10
    View PubMed
  162. Folmes CDL, Nelson TJ, Dzeja PP, Terzic A. Energy metabolism plasticity enables stemness programs. Ann N Y Acad Sci. 2012 Apr; 1254:82-89
    View PubMed
  163. Waldman SA, Terzic A. The value proposition of molecular medicine. Clin Transl Sci. 2012 Feb; 5(1):108-10. Epub 2012 Feb 23.
    View PubMed
  164. Alekseev AE, Reyes S, Selivanov VA, Dzeja PP, Terzic A. Compartmentation of membrane processes and nucleotide dynamics in diffusion-restricted cardiac cell microenvironment. J Mol Cell Cardiol. 2012 Feb; 52 (2):401-9 Epub 2011 June 16
    View PubMed
  165. Holmuhamedov EL, Oberlin A, Short K, Terzic A, Jahangir A. Cardiac subsarcolemmal and interfibrillar mitochondria display distinct responsiveness to protection by diazoxide. PLoS One. 2012; 7(9):e44667. Epub 2012 Sep 04.
    View PubMed
  166. Waldman SA, Terzic A. Clinical pharmacology therapeutics 2011: Year in review. Clin Pharmacol Ther. 2012; 91(3):353-7.
  167. Ohmine S, Squillace KA, Hartjes KA, Deeds MC, Armstrong AS, Thatava T, Sakuma T, Terzic A, Kudva Y, Ikeda Y. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging (Albany NY). 2012 Jan; 4 (1):60-73
    View PubMed
  168. Waldman SA, Terzic A. Patient-centric clinical pharmacology advances the path to personalized medicine. Biomark Med. 2011 Dec; 5(6):697-700.
    View PubMed
  169. Folmes CD, Nelson TJ, Terzic A. Energy metabolism in nuclear reprogramming. Biomark Med. 2011 Dec; 5: (6)715-29.
    View PubMed
  170. Kang L, Yamada S, Hernandez MC, Croatt AJ, Grande JP, Juncos JP, Vercellotti GM, Hebbel RP, Katusic ZS, Terzic A, Nath KA. Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula. Am J Physiol Renal Physiol. 2011 Oct; 301 (4):F845-51 Epub 2011 June 22
    View PubMed
  171. Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011 Aug 3; 14 (2):264-71
    View PubMed
  172. Muller O, Delrue L, Hamilos M, Vercauteren S, Ntalianis A, Trana C, Mangiacapra F, Dierickx K, De Bruyne B, Wijns W, Behfar A, Barbato E, Terzic A, Vanderheyden M, Bartunek J. Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction. EuroIntervention. 2011 Aug; 7(4):458-66.
    View PubMed
  173. Terzic A, Alekseev AE, Yamada S, Reyes S, Olson TM. Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations. Circ Arrhythm Electrophysiol. 2011 Aug; 4 (4):577-85
    View PubMed
  174. Juranic N, Nemutlu E, Zhang S, Dzeja P, Terzic A, Macura S. (31)P NMR correlation maps of (18)O/ (16)O chemical shift isotopic effects for phosphometabolite labeling studies. J Biomol NMR. 2011 Jul; 50 (3):237-45 Epub 2011 May 25
    View PubMed
  175. Terzic A, Waldman S. Chronic diseases: the emerging pandemic. Clin Transl Sci. 2011 Jun; 4 (3):225-6
    View PubMed
  176. Terzic A, Edwards BS, McKee KC, Nelson TJ. Regenerative medicine: a reality of stem cell technology. Minn Med. 2011 May; 94(5):44-7.
    View PubMed
  177. Arrell DK, Zlatkovic Lindor J, Yamada S, Terzic A. K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy. Cardiovasc Res. 2011 May 1; 90 (2):258-66 Epub 2011 Feb 14
    View PubMed
  178. Nelson TJ, Terzic A. Induced pluripotent stem cells: an emerging theranostics platform. Clin Pharmacol Ther. 2011 May; 89(5):648-50.
    View PubMed
  179. Dzeja PP, Chung S, Faustino RS, Behfar A, Terzic A. Developmental enhancement of adenylate kinase-AMPK metabolic signaling axis supports stem cell cardiac differentiation. PLoS One. 2011 Apr 27; 6 (4):e19300
    View PubMed
  180. Martinez-Fernandez A, Nelson TJ, Terzic A. Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells. J Cardiovasc Transl Res. 2011 Apr; 4 (2):131-7 Epub 2011 Jan 05
    View PubMed
  181. Bardelli S, Astori G, Surder D, Tallone T, Terzic A, Soldati G, Moccetti T. Stem cell update: highlights from the 2010 Lugano Stem Cell Meeting. J Cardiovasc Transl Res. 2011 Apr; 4(2):192-9. Epub 2010 Oct 30.
    View PubMed
  182. Waldman SA, Terzic A. Bionic technologies transforming the science of healthcare delivery. Clin Transl Sci. 2011 Apr; 4(2):84-6.
    View PubMed
  183. Thatava T, Nelson TJ, Edukulla R, Sakuma T, Ohmine S, Tonne JM, Yamada S, Kudva Y, Terzic A, Ikeda Y. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Ther. 2011 Mar; 18 (3):283-93 Epub 2010 Nov 04
    View PubMed
  184. Waldman SA, Terzic A. Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise. Clin Transl Sci. 2011 Feb; 4(1):69-71.
    View PubMed
  185. Crespo-Diaz R, Behfar A, Butler GW, Padley DJ, Sarr MG, Bartunek J, Dietz AB, Terzic A. Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant. 2011; 20 (6):797-811 Epub 2010 Nov 19
    View PubMed
  186. Banovic M, Ostojic MC, Bartunek J, Nedeljkovic M, Beleslin B, Terzic A. Brachial approach to NOGA-guided procedures: electromechanical mapping and transendocardial stem-cell injections. Tex Heart Inst J. 2011; 38(2):179-82.
    View PubMed
  187. Waldman SA, Terzic A. Year in review. Clin Pharmacol Ther. 2011; 89(3):328-32.
  188. Nelson TJ, Martinez-Fernandez A, Terzic A. Induced pluripotent stem cells: developmental biology to regenerative medicine. Nat Rev Cardiol. 2010 Dec; 7 (12):700-10 Epub 2010 Oct 19
    View PubMed
  189. Reyes S, Park S, Terzic A, Alekseev AE. K(ATP) channels process nucleotide signals in muscle thermogenic response. Crit Rev Biochem Mol Biol. 2010 Dec; 45 (6):506-19 Epub 2010 Oct 07
    View PubMed
  190. Chiriac A, Terzic A, Park S, Ikeda Y, Faustino R, Nelson TJ. SDF-1-enhanced cardiogenesis requires CXCR4 induction in pluripotent stem cells. J Cardiovasc Transl Res. 2010 Dec; 3 (6):674-82 Epub 2010 Sept 15
    View PubMed
  191. Waldman SA, Terzic A. Clinical and translational science: from bench-bedside to global village. Clin Transl Sci. 2010 Oct; 3(5):254-7.
    View PubMed
  192. Behfar A, Crespo-Diaz R, Nelson TJ, Terzic A, Gersh BJ. Stem cells: clinical trials results the end of the beginning or the beginning of the end? Cardiovasc Hematol Disord Drug Targets. 2010 Sep 1; 10 (3):186-201
    View PubMed
  193. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol. 2010 Aug 24; 56 (9):721-34
    View PubMed
  194. Zlatkovic-Lindor J, Arrell DK, Yamada S, Nelson TJ, Terzic A. ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy. Stem Cells. 2010 Aug; 28 (8):1355-67
    View PubMed
  195. Waldman SA, Terzic A. Molecular therapy drives patient-centric health care paradigms. Clin Transl Sci. 2010 Aug; 3(4):170-1.
    View PubMed
  196. Terzic A, Perez-Terzic C. Channelopathies: decoding disease pathogenesis. Sci Transl Med. 2010 Jul 28; 2(42):42ps37.
    View PubMed
  197. Arrell DK, Terzic A. Network systems biology for drug discovery. Clin Pharmacol Ther. 2010 Jul; 88 (1):120-5 Epub 2010 June 02
    View PubMed
  198. Faustino RS, Chiriac A, Niederlander NJ, Nelson TJ, Behfar A, Mishra PK, Macura S, Michalak M, Terzic A, Perez-Terzic C. Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype. Stem Cells. 2010 Jul; 28 (7):1281-91
    View PubMed
  199. Olson TM, Terzic A. Human K(ATP) channelopathies: diseases of metabolic homeostasis. Pflugers Arch. 2010 Jul; 460 (2):295-306 Epub 2009 Dec 24
    View PubMed
  200. Valentino MA, Terzic A, Waldman SA. Sizing up pharmacotherapy for obesity. Clin Transl Sci. 2010 Jun; 3(3):123-5.
    View PubMed
  201. Bartunek J, Vanderheyden M, Hill J, Terzic A. Cells as biologics for cardiac repair in ischaemic heart failure. Heart. 2010 May; 96(10):792-800.
    View PubMed
  202. Chiriac A, Nelson TJ, Faustino RS, Behfar A, Terzic A. Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1/VEGF/BMP2 integrated network. PLoS One. 2010 Apr 1; 5 (4):e9943 Epub 2010 Apr 01
    View PubMed
  203. Chung S, Arrell DK, Faustino RS, Terzic A, Dzeja PP. Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. J Mol Cell Cardiol. 2010 Apr; 48 (4):725-34 Epub 2010 Jan 04
    View PubMed
  204. Martinez-Fernandez A, Nelson TJ, Ikeda Y, Terzic A. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells. J Cardiovasc Transl Res. 2010 Feb; 3 (1):13-23
    View PubMed
  205. Zhao Q, Beck A, Vitale JM, Schneider JS, Terzic A, Fraidenraich D. Rescue of developmental defects by blastocyst stem cell injection: towards elucidation of neomorphic corrective pathways. J Cardiovasc Transl Res. 2010 Feb; 3(1):66.
    View PubMed
  206. Park S, Terzic A. Quaternary structure of K-ATP channel SUR2A nucleotide binding domains resolved by synchrotron radiation X-ray scattering. J Struct Biol. 2010 Feb; 169(2):243-51.
  207. Park S, Terzic A. Quaternary structure of KATP channel SUR2A nucleotide binding domains resolved by synchrotron radiation X-ray scattering. J Struct Biol. 2010 Feb; 169 (2):243-51 Epub 2009 Nov 15
    View PubMed
  208. Alekseev AE, Reyes S, Yamada S, Hodgson-Zingman DM, Sattiraju S, Zhu Z, Sierra A, Gerbin M, Coetzee WA, Goldhamer DJ, Terzic A, Zingman LV. Sarcolemmal ATP-sensitive K(+) channels control energy expenditure determining body weight. Cell Metab. 2010 Jan; 11 (1):58-69
    View PubMed
  209. Nelson TJ, Martinez-Fernandez A, Yamada S, Ikeda Y, Perez-Terzic C, Terzic A. Induced pluripotent stem cells: advances to applications. Stem Cells Cloning. 2010 Jan 1; 3:29-37
    View PubMed
  210. Waldman SA, Kraft WK, Nelson TJ, Terzic A. Clinical pharmacology: a paradigm for individualized medicine. Biomark. Med. 2009 Dec; 3(6):679-84.
  211. Schneider JS, Vitale JM, Terzic A, Fraidenraich D. Blastocyst injection of embryonic stem cells: a simple approach to unveil mechanisms of corrections in mouse models of human disease. Stem Cell Rev. 2009 Dec; 5(4):369-77. Epub 2009 Aug 25.
    View PubMed
  212. Waldman SA, Kraft WK, Nelson TJ, Terzic A. Experimental therapeutics: a paradigm for personalized medicine. Clin Transl Sci. 2009 Dec; 2(6):436-8.
    View PubMed
  213. Reyes S, Park S, Johnson BD, Terzic A, Olson TM. KATP channel Kir6.2 E23K variant overrepresented in human heart failure is associated with impaired exercise stress response. Hum Genet. 2009 Dec; 126 (6):779-89
    View PubMed
  214. Frye RL, Simari RD, Gersh BJ, Burnett JC, Brumm S, Myerle K, Jaffe AS, Holmes DR, Lerman A, Terzic A. Ethical issues in cardiovascular research involving humans. Circulation. 2009 Nov 24; 120 (21):2113-21
    View PubMed
  215. Reyes S, Kane GC, Zingman LV, Yamada S, Terzic A. Targeted disruption of K(ATP) channels aggravates cardiac toxicity in cocaine abuse. Clin Transl Sci. 2009 Oct; 2 (5):361-5
    View PubMed
  216. Arrell DK, Zlatkovic J, Kane GC, Yamada S, Terzic A. ATP-sensitive K+ channel knockout induces cardiac proteome remodeling predictive of heart disease susceptibility. J Proteome Res. 2009 Oct; 8 (10):4823-34
    View PubMed
  217. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009 Oct; 84 (10):876-92
    View PubMed
  218. Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res. 2009 Sep 25; 105 (7):648-56 Epub 2009 Aug 20
    View PubMed
  219. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009 Aug 4; 120 (5):408-16 Epub 2009 July 20
    View PubMed
  220. Yamada S, Nelson TJ, Behfar A, Crespo-Diaz RJ, Fraidenraich D, Terzic A. Stem cell transplant into preimplantation embryo yields myocardial infarction-resistant adult phenotype. Stem Cells. 2009 Jul; 27 (7):1697-705
    View PubMed
  221. Nelson TJ, Behfar A, Yamada S, Martinez-Fernandez A, Terzic A. Stem cell platforms for regenerative medicine. Clin Transl Sci. 2009 Jun; 2 (3):222-7
    View PubMed
  222. Bartunek J, Sherman W, Vanderheyden M, Fernandez-Aviles F, Wijns W, Terzic A. Delivery of biologics in cardiovascular regenerative medicine. Clin Pharmacol Ther. 2009 May; 85(5):548-52. Epub 2009 Feb 11.
    View PubMed
  223. Dzeja P, Terzic A. Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing. Int J Mol Sci. 2009 Apr 17; 10 (4):1729-1772
    View PubMed
  224. Nelson TJ, Martinez-Fernandez A, Yamada S, Mael AA, Terzic A, Ikeda Y. Induced pluripotent reprogramming from promiscuous human stemness related factors. Clin Transl Sci. 2009 Apr; 2 (2):118-26
    View PubMed
  225. Zlatkovic J, Arrell DK, Kane GC, Miki T, Seino S, Terzic A. Proteomic profiling of KATP channel-deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome. Proteomics. 2009 Mar; 9 (5):1314-25
    View PubMed
  226. Nelson TJ, Chiriac A, Faustino RS, Crespo-Diaz RJ, Behfar A, Terzic A. Lineage specification of Flk-1+ progenitors is associated with divergent Sox7 expression in cardiopoiesis. Differentiation. 2009 Mar; 77 (3):248-55 Epub 2008 Dec 02
    View PubMed
  227. Nelson TJ, Martinez-Fernandez A, Terzic A. KCNJ11 knockout morula re-engineered by stem cell diploid aggregation. Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27; 364 (1514):269-76
    View PubMed
  228. Waldman SA, Terzic A. Translational medicine in the era of health care reform. Clinical and Translational Science. 2009; 2(2):96-7.
  229. Waldman SA, Terzic A. Applications of MicroRNA in cancer: Exploring the advantages of miRNA. Clinical and Translational Science. 2009; 2(3):248-9.
  230. Chung S, Dzeja PP, Faustino RS, Terzic A. Developmental restructuring of the creatine kinase system integrates mitochondrial energetics with stem cell cardiogenesis. Ann N Y Acad Sci. 2008 Dec; 1147:254-63
    View PubMed
  231. Nelson T, Behfar A, Terzic A. Stem cells: biologics for regeneration. Clin Pharmacol Ther. 2008 Nov; 84(5):620-3. Epub 2008 Aug 13.
    View PubMed
  232. Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A. Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol. 2008 Oct; 45 (4):523-9 Epub 2008 Sept 26
    View PubMed
  233. Doyle B, Sorajja P, Hynes B, Kumar AH, Araoz PA, Stalboerger PG, Miller D, Reed C, Schmeckpeper J, Wang S, Liu C, Terzic A, Kruger D, Riederer S, Caplice NM. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev. 2008 Oct; 17(5):941-51.
    View PubMed
  234. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A, Terzic A. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells. 2008 Oct; 26(10):2644-53. Epub 2008 Jul 31.
    View PubMed
  235. Faustino RS, Chiriac A, Terzic A. Bioinformatic primer for clinical and translational science. Clin Transl Sci. 2008 Sep; 1 (2):174-80
    View PubMed
  236. Nelson TJ, Behfar A, Terzic A. Strategies for therapeutic repair: The "R(3)" regenerative medicine paradigm. Clin Transl Sci. 2008 Sep; 1 (2):168-171
    View PubMed
  237. Korinek J, Sengupta PP, Wang J, Romero-Corral A, Boukatina AE, Vitek J, Krishnamoorthy VK, Cha SS, Dzeja PP, Terzic A, Khandheria BK, Belohlavek M. Doppler strain imaging closely reflects myocardial energetic status in acute progressive ischemia and indicates energetic recovery after reperfusion. J Am Soc Echocardiogr. 2008 Aug; 21 (8):961-8 Epub 2008 Mar 06
    View PubMed
  238. Baker DJ, Perez-Terzic C, Jin F, Pitel KS, Niederlander NJ, Jeganathan K, Yamada S, Reyes S, Rowe L, Hiddinga HJ, Eberhardt NL, Terzic A, van Deursen JM. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat Cell Biol. 2008 Jul; 10 (7):825-36 Epub 2008 May 30
    View PubMed
  239. Reyes S, Terzic A, Mahoney DW, Redfield MM, Rodeheffer RJ, Olson TM. K(ATP) channel polymorphism is associated with left ventricular size in hypertensive individuals: a large-scale community-based study. Hum Genet. 2008 Jul; 123 (6):665-7 Epub 2008 May 27
    View PubMed
  240. Faustino RS, Terzic A. Interactome of a cardiopoietic precursor. J Cardiovasc Transl Res. 2008 Jun; 1 (2):120-6 Epub 2008 June 03
    View PubMed
  241. Nelson TJ, Faustino RS, Chiriac A, Crespo-Diaz R, Behfar A, Terzic A. CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells. 2008 Jun; 26(6):1464-73. Epub 2008 Mar 27.
    View PubMed
  242. Preston CC, Oberlin AS, Holmuhamedov EL, Gupta A, Sagar S, Syed RH, Siddiqui SA, Raghavakaimal S, Terzic A, Jahangir A. Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart. Mech Ageing Dev. 2008 Jun; 129 (6):304-12 Epub 2008 Mar 04
    View PubMed
  243. Behfar A, Terzic A. Mesenchymal stem cells: engineering regeneration. Clin Transl Sci. 2008 May; 1 (1):34-5
    View PubMed
  244. Park S, Lim BB, Perez-Terzic C, Mer G, Terzic A. Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity. J Proteome Res. 2008 Apr; 7 (4):1721-8 Epub 2008 Mar 01
    View PubMed
  245. Karger AB, Park S, Reyes S, Bienengraeber M, Dyer RB, Terzic A, Alekseev AE. Role for SUR2A ED domain in allosteric coupling within the K(ATP) channel complex. J Gen Physiol. 2008 Mar; 131 (3):185-96
    View PubMed
  246. Arrell DK, Niederlander NJ, Faustino RS, Behfar A, Terzic A. Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells. 2008 Feb; 26(2):387-400. Epub 2007 Nov 08.
    View PubMed
  247. Sattiraju S, Reyes S, Kane GC, Terzic A. K(ATP) channel pharmacogenomics: from bench to bedside. Clin Pharmacol Ther. 2008 Feb; 83 (2):354-7 Epub 2007 Oct 24
    View PubMed
  248. Faustino RS, Behfar A, Perez-Terzic C, Terzic A. Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol. 2008 Jan 9; 9 (1):R6 Epub 2008 Jan 09
    View PubMed
  249. Waldman SA, Terzic A. Clinical and translational sciences: At the intersection of molecular and individualized medicine. Clinical and Translational Science. 2008; 1(1):6-8.
  250. Nelson TJ, Behfar A, Terzic A. Strategies for therapeutic repair: The "R3" regenerative medicine paradigm. Clinical and Translational Science. 2008; 1(2):168-71.
  251. Jahangir A, Sagar S, Terzic A. Aging and cardioprotection. J Appl Physiol (1985). 2007 Dec; 103 (6):2120-8 Epub 2007 Aug 23
    View PubMed
  252. Tracz MJ, Juncos JP, Croatt AJ, Ackerman AW, Grande JP, Knutson KL, Kane GC, Terzic A, Griffin MD, Nath KA. Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int. 2007 Nov; 72 (9):1073-80 Epub 2007 Aug 29
    View PubMed
  253. Zingman LV, Alekseev AE, Hodgson-Zingman DM, Terzic A. ATP-sensitive potassium channels: metabolic sensing and cardioprotection. J Appl Physiol. 2007 Nov; 103(5):1888-93.
  254. Dzeja PP, Bast P, Pucar D, Wieringa B, Terzic A. Defective metabolic signaling in adenylate kinase AK1 gene knock-out hearts compromises post-ischemic coronary reflow. J Biol Chem. 2007 Oct 26; 282 (43):31366-72 Epub 2007 Aug 17
    View PubMed
  255. Behfar A, Terzic A. Cardioprotective repair through stem cell-based cardiopoiesis. J Appl Physiol (1985). 2007 Oct; 103(4):1438-40. Epub 2007 Jul 19.
    View PubMed
  256. Ozcan C, Terzic A, Bienengraeber M. Effective pharmacotherapy against oxidative injury: alternative utility of an ATP-sensitive potassium channel opener. J Cardiovasc Pharmacol. 2007 Oct; 50(4):411-8.
    View PubMed
  257. Arrell DK, Niederlander NJ, Perez-Terzic C, Chung S, Behfar A, Terzic A. Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics. Clin Pharmacol Ther. 2007 Sep; 82(3):316-9. Epub 2007 Aug 01.
    View PubMed
  258. Taneja V, Behrens M, Cooper LT, Yamada S, Kita H, Redfield MM, Terzic A, David C. Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. J Mol Cell Cardiol. 2007 Jun; 42 (6):1054-64 Epub 2007 Mar 27
    View PubMed
  259. Faustino RS, Nelson TJ, Terzic A, Perez-Terzic C. Nuclear transport: target for therapy. Clin Pharmacol Ther. 2007 Jun; 81(6):880-6. Epub 2007 Apr 18.
    View PubMed
  260. Gumina RJ, O'Cochlain DF, Kurtz CE, Bast P, Pucar D, Mishra P, Miki T, Seino S, Macura S, Terzic A. KATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart. Am J Physiol Heart Circ Physiol. 2007 Apr; 292 (4):H1706-13 Epub 2006 Dec 22
    View PubMed
  261. Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederlander N, Alekseev AE, Zingman LV, Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med. 2007 Feb 19; 204 (2):405-20 Epub 2007 Feb 05
    View PubMed
  262. Perez-Terzic C, Faustino RS, Boorsma BJ, Arrell DK, Niederlander NJ, Behfar A, Terzic A. Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1:S68-76.
    View PubMed
  263. Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1 (Suppl 1):S60-7
    View PubMed
  264. Olson TM, Alekseev AE, Moreau C, Liu XK, Zingman LV, Miki T, Seino S, Asirvatham SJ, Jahangir A, Terzic A. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4(2):110-6.
    View PubMed
  265. Zingman LV, Park S, Olson TM, Alekseev AE, Terzic A. Aminoglycoside-induced translational read-through in disease: Overcoming nonsense mutations by pharmacogenetic therapy. Clin Pharmacol Ther. 2007 Jan; 81(1):99-103.
    View PubMed
  266. Yamada S, Kane GC, Behfar A, Liu XK, Dyer RB, Faustino RS, Miki T, Seino S, Terzic A. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J Physiol. 2006 Dec 15; 577(Pt 3):1053-65. Epub 2006 Oct 12.
    View PubMed
  267. Kane GC, Lam CF, O'Cochlain F, Hodgson DM, Reyes S, Liu XK, Miki T, Seino S, Katusic ZS, Terzic A. Gene knockout of the KCNJ8-encoded Kir6.1 K(ATP) channel imparts fatal susceptibility to endotoxemia. FASEB J. 2006 Nov; 20(13):2271-80.
    View PubMed
  268. Kane GC, Behfar A, Dyer RB, O'Cochlain DF, Liu XK, Hodgson DM, Reyes S, Miki T, Seino S, Terzic A. KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. Hum Mol Genet. 2006 Aug 01; 15(15):2285-97. Epub 2006 Jun 16.
    View PubMed
  269. Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A, Terzic A. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet. 2006 Jul 15; 15(14):2185-91. Epub 2006 Jun 13.
    View PubMed
  270. Cha YM, Dzeja PP, Redfield MM, Shen WK, Terzic A. Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat. Am J Physiol Heart Circ Physiol. 2006 Apr; 290 (4):H1686-92 Epub 2005 Dec 09
    View PubMed
  271. Behfar A, Terzic A. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nat Clin Pract Cardiovasc Med. 2006 Mar; 3 Suppl 1:S78-82
    View PubMed
  272. Saks V, Dzeja P, Schlattner U, Vendelin M, Terzic A, Wallimann T. Cardiac system bioenergetics: metabolic basis of the Frank-Starling law. J Physiol. 2006 Mar 1; 571(Pt 2):253-73. Epub 2006 Jan 12.
    View PubMed
  273. Baker DJ, Jeganathan KB, Malureanu L, Perez-Terzic C, Terzic A, van Deursen JM. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J Cell Biol. 2006 Feb 13; 172 (4):529-40
    View PubMed
  274. Jahangir A, Terzic A. K(ATP) channel therapeutics at the bedside. J Mol Cell Cardiol. 2005 Jul; 39 (1):99-112
    View PubMed
  275. Kane GC, Liu XK, Yamada S, Olson TM, Terzic A. Cardiac KATP channels in health and disease. J Mol Cell Cardiol. 2005 Jun; 38 (6):937-43 Epub 2005 Apr 25
    View PubMed
  276. Alekseev AE, Hodgson DM, Karger AB, Park S, Zingman LV, Terzic A. ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart. J Mol Cell Cardiol. 2005 Jun; 38 (6):895-905 Epub 2005 Apr 14
    View PubMed
  277. Behfar A, Hodgson DM, Zingman LV, Perez-Terzic C, Yamada S, Kane GC, Alekseev AE, Puceat M, Terzic A. Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair. Ann N Y Acad Sci. 2005 May; 1049:189-98.
    View PubMed
  278. Keogh KA, Standing J, Kane GC, Terzic A, Limper AH. Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice. Eur Respir J. 2005 Apr; 25(4):708-14.
    View PubMed
  279. Korinek J, Anagnostopoulos PC, Pislaru C, Dzeja P, Seward JB, Terzic A, Belohlavek M. Both systolic and diastolic dysfunction characterize nonischemic inhibition of myocardial energy metabolism: an experimental strain rate echocardiographic study. J Am Soc Echocardiogr. 2004 Dec; 17: (12)1239-44.
    View PubMed
  280. Kane GC, Behfar A, Yamada S, Perez-Terzic C, O'Cochlain F, Reyes S, Dzeja PP, Miki T, Seino S, Terzic A. ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits. Diabetes. 2004 Dec; 53 Suppl 3:S169-75
    View PubMed
  281. Liu XK, Yamada S, Kane GC, Alekseev AE, Hodgson DM, O'Cochlain F, Jahangir A, Miki T, Seino S, Terzic A. Genetic disruption of Kir6.2, the pore-forming subunit of ATP-sensitive K+ channel, predisposes to catecholamine-induced ventricular dysrhythmia. Diabetes. 2004 Dec; 53 Suppl 3:S165-8.
    View PubMed
  282. He T, Peterson TE, Holmuhamedov EL, Terzic A, Caplice NM, Oberley LW, Katusic ZS. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol. 2004 Nov; 24 (11):2021-7 Epub 2004 Aug 19
    View PubMed
  283. O'Cochlain DF, Perez-Terzic C, Reyes S, Kane GC, Behfar A, Hodgson DM, Strommen JA, Liu XK, van den Broek W, Wansink DG, Wieringa B, Terzic A. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum Mol Genet. 2004 Oct 15; 13(20):2505-18. Epub 2004 Aug 18.
    View PubMed
  284. Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE, Puceat M, Terzic A. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol. 2004 Aug; 287 (2):H471-9
    View PubMed
  285. Liu XK, Jahangir A, Terzic A, Gersh BJ, Hammill SC, Shen WK. Age- and sex-related atrial electrophysiologic and structural changes. Am J Cardiol. 2004 Aug 01; 94(3):373-5.
    View PubMed
  286. Holmuhamedov EL, Jahangir A, Oberlin A, Komarov A, Colombini M, Terzic A. Potassium channel openers are uncoupling protonophores: implication in cardioprotection. FEBS Lett. 2004 Jun 18; 568: (1-3)167-70.
    View PubMed
  287. Bienengraeber M, Olson TM, Selivanov VA, Kathmann EC, O'Cochlain F, Gao F, Karger AB, Ballew JD, Hodgson DM, Zingman LV, Pang YP, Alekseev AE, Terzic A. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet. 2004 Apr; 36 (4):382-7 Epub 2004 Mar 21
    View PubMed
  288. Dzeja PP, Terzic A, Wieringa B. Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice. Mol Cell Biochem. 2004 Jan-Feb; 256(1-2):13-27.
    View PubMed
  289. Janssen E, Kuiper J, Hodgson D, Zingman LV, Alekseev AE, Terzic A, Wieringa B. Two structurally distinct and spatially compartmentalized adenylate kinases are expressed from the AK1 gene in mouse brain. Mol Cell Biochem. 2004 Jan-Feb; 256(1-2):59-72.
    View PubMed
  290. Selivanov VA, Alekseev AE, Hodgson DM, Dzeja PP, Terzic A. Nucleotide-gated KATP channels integrated with creatine and adenylate kinases: amplification, tuning and sensing of energetic signals in the compartmentalized cellular environment. Mol Cell Biochem. 2004 Jan-Feb; 256-257 (1-2):243-56
    View PubMed
  291. Pucar D, Dzeja PP, Bast P, Gumina RJ, Drahl C, Lim L, Juranic N, Macura S, Terzic A. Mapping hypoxia-induced bioenergetic rearrangements and metabolic signaling by 18O-assisted 31P NMR and 1H NMR spectroscopy. Mol Cell Biochem. 2004 Jan-Feb; 256-257 (1-2):281-9
    View PubMed
  292. Trushina E, Heldebrant MP, Perez-Terzic CM, Bortolon R, Kovtun IV, Badger JD 2nd, Terzic A, Estevez A, Windebank AJ, Dyer RB, Yao J, McMurray CT. Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci U S A. 2003 Oct 14; 100 (21):12171-6 Epub 2003 Oct 03
    View PubMed
  293. Ozcan C, Bienengraeber M, Hodgson DM, Mann DL, Terzic A. Mitochondrial tolerance to stress impaired in failing heart. J Mol Cell Cardiol. 2003 Sep; 35 (9):1161-6
    View PubMed
  294. Janssen E, Terzic A, Wieringa B, Dzeja PP. Impaired intracellular energetic communication in muscles from creatine kinase and adenylate kinase (M-CK/AK1) double knock-out mice. J Biol Chem. 2003 Aug 15; 278(33):30441-9.
    View PubMed
  295. Holmuhamedov E, Jahangir A, Bienengraeber M, Lewis LD, Terzic A. Deletion of mtDNA disrupts mitochondrial function and structure, but not biogenesis. Mitochondrion. 2003 Aug; 3: (1)13-9.
    View PubMed
  296. Bienengraeber M, Ozcan C, Terzic A. Stable transfection of UCP1 confers resistance to hypoxia/reoxygenation in a heart-derived cell line. J Mol Cell Cardiol. 2003 Jul; 35 (7):861-5
    View PubMed
  297. Gumina RJ, Pucar D, Bast P, Hodgson DM, Kurtz CE, Dzeja PP, Miki T, Seino S, Terzic A. Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics. Am J Physiol Heart Circ Physiol. 2003 Jun; 284 (6):H2106-13 Epub 2003 Feb 21
    View PubMed
  298. Dzeja PP, Terzic A. Phosphotransfer networks and cellular energetics. J Exp Biol. 2003 Jun; 206 (Pt 12):2039-47
    View PubMed
  299. Hodgson DM, Zingman LV, Kane GC, Perez-Terzic C, Bienengraeber M, Ozcan C, Gumina RJ, Pucar D, O'Coclain F, Mann DL, Alekseev AE, Terzic A. Cellular remodeling in heart failure disrupts K(ATP) channel-dependent stress tolerance. EMBO J. 2003 Apr 15; 22 (8):1732-42
    View PubMed
  300. Janssen E, de Groof A, Wijers M, Fransen J, Dzeja PP, Terzic A, Wieringa B. Adenylate kinase 1 deficiency induces molecular and structural adaptations to support muscle energy metabolism. J Biol Chem. 2003 Apr 11; 278(15):12937-45.
    View PubMed
  301. Cha YM, Dzeja PP, Shen WK, Jahangir A, Hart CY, Terzic A, Redfield MM. Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability. Am J Physiol Heart Circ Physiol. 2003 Apr; 284 (4):H1313-20
    View PubMed
  302. Dzeja PP, Bast P, Ozcan C, Valverde A, Holmuhamedov EL, Van Wylen DG, Terzic A. Targeting nucleotide-requiring enzymes: implications for diazoxide-induced cardioprotection. Am J Physiol Heart Circ Physiol. 2003 Apr; 284 (4):H1048-56
    View PubMed
  303. Perez-Terzic C, Behfar A, Mery A, van Deursen JMA, Terzic A, Puceat M. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res. 2003 Mar 7; 92(4):444-52.
    View PubMed
  304. Pitari GM, Zingman LV, Hodgson DM, Alekseev AE, Kazerounian S, Bienengraeber M, Hajnozky G, Terzic A, Waldman SA. Bacterial enterotoxins are associated with resistance to colon cancer. Proc Natl Acad Sci U S A. 2003 Mar 4; 100(5):2695-9.
    View PubMed
  305. Cha Y, Dzeja P, Shen W, Jahangir A, Hart C, Terzic A, Redfield M. Bioenergetic deficits associated with atrial structural and electrophysiological remodeling in experimental congestive heart failure. AJP. 2003; 284:H1313-1320.
  306. Mery A, Papadimou E, Zeineddine D, Menard C, Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Perez-Terzic C, Terzic A, Puceat M. Commitment of embryonic stem cells toward a cardiac lineage: molecular mechanisms and evidence for a promising therapeutic approach for heart failure. J Muscle Res Cell Motil. 2003; 24(4-6):269-74.
    View PubMed
  307. Trushina YV, Heldebrant M, Kovtun I, Perez-Terzic C, Terzic A, Estevez J, Bortolon R, Windebank A, Dyer RD, McMurray CT. Single cell analysis of primary neurons: toxicity of the Huntington's protein initiates in the cytoplasm Proc. Natl Acad Sci. 2003; 100:12171-6.
  308. Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A, Puceat M. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 2002 Oct; 16(12):1558-66.
    View PubMed
  309. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE, Terzic A. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci U S A. 2002 Oct 1; 99 (20):13278-83 Epub 2002 Sept 23
    View PubMed
  310. Pucar D, Bast P, Gumina RJ, Lim L, Drahl C, Juranic N, Macura S, Janssen E, Wieringa B, Terzic A, Dzeja PP. Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2002 Aug; 283 (2):H776-82
    View PubMed
  311. Dzeja PP, Bortolon R, Perez-Terzic C, Holmuhamedov EL, Terzic A. Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer. Proc Natl Acad Sci U S A. 2002 Jul 23; 99 (15):10156-61 Epub 2002 July 15
    View PubMed
  312. Abraham MR, Selivanov VA, Hodgson DM, Pucar D, Zingman LV, Wieringa B, Dzeja PP, Alekseev AE, Terzic A. Coupling of cell energetics with membrane metabolic sensing. Integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out. J Biol Chem. 2002 Jul 5; 277 (27):24427-34 Epub 2002 Apr 19
    View PubMed
  313. Holmuhamedov E, Lewis L, Bienengraeber M, Holmuhamedova M, Jahangir A, Terzic A. Suppression of human tumor cell proliferation through mitochondrial targeting. FASEB J. 2002 Jul; 16(9):1010-6.
    View PubMed
  314. Zingman LV, Hodgson DM, Bienengraeber M, Karger AB, Kathmann EC, Alekseev AE, Terzic A. Tandem function of nucleotide binding domains confers competence to sulfonylurea receptor in gating ATP-sensitive K+ channels. J Biol Chem. 2002 Apr 19; 277 (16):14206-10 Epub 2002 Feb 01
    View PubMed
  315. Ozcan C, Bienengraeber M, Dzeja PP, Terzic A. Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol. 2002 Feb; 282 (2):H531-9
    View PubMed
  316. Jahangir A, Terzic A, Shen WK. Potassium channel openers: therapeutic potential in cardiology and medicine. Expert Opin Pharmacother. 2001 Dec; 2 (12):1995-2010
    View PubMed
  317. Pucar D, Dzeja PP, Bast P, Juranic N, Macura S, Terzic A. Cellular energetics in the preconditioned state: protective role for phosphotransfer reactions captured by 18O-assisted 31P NMR. J Biol Chem. 2001 Nov 30; 276 (48):44812-9 Epub 2001 Oct 02
    View PubMed
  318. Melamed-Frank M, Terzic A, Carrasco AJ, Nevo E, Avivi A, Levy AP. Reciprocal regulation of expression of pore-forming KATP channel genes by hypoxia. Mol Cell Biochem. 2001 Sep; 225(1-):145-50.
    View PubMed
  319. Zingman LV, Alekseev AE, Bienengraeber M, Hodgson D, Karger AB, Dzeja PP, Terzic A. Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance. Neuron. 2001 Aug 2; 31 (2):233-45
    View PubMed
  320. Jahangir A, Ozcan C, Holmuhamedov EL, Terzic A. Increased calcium vulnerability of senescent cardiac mitochondria: protective role for a mitochondrial potassium channel opener. Mech Ageing Dev. 2001 Jul 31; 122 (10):1073-86
    View PubMed
  321. Gumina RJ, Terzic A, Gross GJ. Do NHE inhibition and ischemic preconditioning convey cardioprotection through a common mechanism? Basic Res Cardiol. 2001 Jul; 96 (4):318-24
    View PubMed
  322. Carrasco AJ, Dzeja PP, Alekseev AE, Pucar D, Zingman LV, Abraham MR, Hodgson D, Bienengraeber M, Puceat M, Janssen E, Wieringa B, Terzic A. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc Natl Acad Sci U S A. 2001 Jun 19; 98 (13):7623-8 Epub 2001 June 05
    View PubMed
  323. Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, Terzic A. Directed inhibition of nuclear import in cellular hypertrophy. J Biol Chem. 2001 Jun 8; 276 (23):20566-71 Epub 2001 Mar 30
    View PubMed
  324. Gumina RJ, Jahangir A, Gross GJ, Terzic A. Cardioprotection: emerging pharmacotherapy. Expert Opin Pharmacother. 2001 May; 2 (5):739-52
    View PubMed
  325. Holmuhamedov EL, Ozcan C, Jahangir A, Terzic A. Restoration of Ca2+-inhibited oxidative phosphorylation in cardiac mitochondria by mitochondrial Ca2+ unloading. Mol Cell Biochem. 2001 Apr; 220 (1-2):135-40
    View PubMed
  326. Ozcan C, Holmuhamedov EL, Jahangir A, Terzic A. Diazoxide protects mitochondria from anoxic injury: implications for myopreservation. J Thorac Cardiovasc Surg. 2001 Feb; 121(2):298-306.
    View PubMed
  327. Pucar D, Janssen E, Dzeja PP, Juranic N, Macura S, Wieringa B, Terzic A. Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress. J Biol Chem. 2000 Dec 29; 275 (52):41424-9
    View PubMed
  328. Janssen E, Dzeja PP, Oerlemans F, Simonetti AW, Heerschap A, de Haan A, Rush PS, Terjung RR, Wieringa B, Terzic A. Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. EMBO J. 2000 Dec 1; 19(23):6371-81.
    View PubMed
  329. Bienengraeber M, Alekseev AE, Abraham MR, Carrasco AJ, Moreau C, Vivaudou M, Dzeja PP, Terzic A. ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex. FASEB J. 2000 Oct; 14 (13):1943-52
    View PubMed
  330. Jovanovic S, Jovanovic A, Shen WK, Terzic A. Low concentrations of 17beta-estradiol protect single cardiac cells against metabolic stress-induced Ca2+ loading. J Am Coll Cardiol. 2000 Sep; 36 (3):948-52
    View PubMed
  331. Lisy O, Redfield MM, Jovanovic S, Jougasaki M, Jovanovic A, Leskinen H, Terzic A, Burnett JC Jr. Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function In vivo. Circulation. 2000 Jul 18; 102 (3):338-43
    View PubMed
  332. Jaconi M, Bony C, Richards SM, Terzic A, Arnaudeau S, Vassort G, Puceat M. Inositol 1,4,5-trisphosphate directs Ca2+ flow between mitochondria and the endoplasmic/sarcoplasmic reticulum: A role in regulating cardiac autonomic Ca2+ spiking. Mol Biol Cell. 2000 May; 11(5):1845-1858.
    View PubMed
  333. Dzeja PP, Redfield MM, Burnett JC, Terzic A. Failing energetics in failing hearts. Curr Cardiol Rep. 2000 May; 2 (3):212-7
    View PubMed
  334. Chen HH, Oh KY, Terzic A, Burnett JC Jr. The modulating actions of sulfonylurea on atrial natriuretic peptide release in experimental acute heart failure. Eur J Heart Fail. 2000 Mar; 2 (1):33-40
    View PubMed
  335. Dzeja PP, Pucar D, Redfield MM, Burnett JC, Terzic A. Reduced activity of enzymes coupling ATP-generating with ATP-consuming processes in the failing myocardium. Mol Cell Biochem. 1999 Nov; 201 (1-2):33-40
    View PubMed
  336. Abraham MR, Jahangir A, Alekseev AE, Terzic A. Channelopathies of inwardly rectifying potassium channels. FASEB J. 1999 Nov; 13 (14):1901-10
    View PubMed
  337. D'hahan N, Moreau C, Prost AL, Jacquet H, Alekseev AE, Terzic A, Vivaudou M. Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc Natl Acad Sci U S A. 1999 Oct 12; 96(21):12162-7.
    View PubMed
  338. Waldman SA, Terzic A. The Molecular Therapeutics Section of the American Society for Clinical Pharmacology and Therapeutics. Clinical Pharmacology & Therapeutics. 1999 Oct; 66(4):336-7.
    View PubMed
  339. Holmuhamedov EL, Wang L, Terzic A. ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J Physiol. 1999 Sep 1; 519 Pt 2 (Pt 2):347-60
    View PubMed
  340. Terzic A. New frontiers of cardioprotection. Clin Pharmacol Ther. 1999 Aug; 66(2):105-9.
    View PubMed
  341. Perez-Terzic C, Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, Terzic A. Structural plasticity of the cardiac nuclear pore complex in response to regulators of nuclear import. Circ Res. 1999 Jun 11; 84 (11):1292-301
    View PubMed
  342. Dzeja PP, Vitkevicius KT, Redfield MM, Burnett JC, Terzic A. Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure. Circ Res. 1999 May 28; 84 (10):1137-43
    View PubMed
  343. Parkinson SJ, Jovanovic A, Jovanovic S, Wagner F, Terzic A, Waldman SA. Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium. Biochemistry. 1999 May 18; 38(20):6441-8.
    View PubMed
  344. Zhang W, Mannan I, Schulz S, Parkinson SJ, Alekseev AE, Gomez LA, Terzic A, Waldman SA. Interruption of transmembrane signaling as a novel antisecretory strategy to treat enterotoxigenic diarrhea. FASEB J. 1999 May; 13(8):913-22.
    View PubMed
  345. Jovanovic N, Jovanovic S, Jovanovic A, Terzic A. Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca2+ homeostasis under metabolic stress. FASEB J. 1999 May; 13 (8):923-9
    View PubMed
  346. Service FJ, Natt N, Thompson GB, Grant CS, van Heerden JA, Andrews JC, Lorenz E, Terzic A, Lloyd RV. Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab. 1999 May; 84: (5)1582-9.
    View PubMed
  347. Serrano OK, Jovanovic A, Terzic A. Inhibition of both Na/H and bicarbonate-dependent exchange is required to prevent recovery of intracellular pH in single cardiomyocytes exposed to metabolic stress. Biosci Rep. 1999 Apr; 19 (2):99-107
    View PubMed
  348. Jovanovic S, Grantham AJ, Tarara JE, Burnett JC Jr, Jovanovic A, Terzic A. Increased number of cardiomyocytes in cross-sections from tachycardia-induced cardiomyopathic hearts. Int J Mol Med. 1999 Feb; 3 (2):153-5
    View PubMed
  349. Lorenz E, Terzic A. Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2A. J Mol Cell Cardiol. 1999 Feb; 31(2):425-34.
    View PubMed
  350. Hibino H, Terzic A, Inanobe A, Horio Y, Kurachi Y. Regulation of ion channels by membrane proteins. Current Topics in Membranes. 1999; 46:243-272.
  351. Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr, Holmes DR Jr. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1999 Jan; 33 (1):119-24
    View PubMed
  352. Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A, Terzic A. Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol. 1998 Nov; 275 (5):H1567-76
    View PubMed
  353. Jovanovic S, Jovanovic A, Shen WK, Terzic A. Protective action of 17beta-estradiol in cardiac cells: implications for hyperkalemic cardioplegia. Ann Thorac Surg. 1998 Nov; 66 (5):1658-61
    View PubMed
  354. Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A, Terzic A. Mitochondrial ATP-sensitive K(+) channels modulate cardiac mitochondrial function. Am J Physiol Heart Circ Physiol. 1998 Nov 1; 275 (5):H1567-H1576
    View PubMed
  355. Jovanovic A, Jovanovic S, Lorenz E, Terzic A. Recombinant cardiac ATP-sensitive K+ channel subunits confer resistance to chemical hypoxia-reoxygenation injury. Circulation. 1998 Oct 13; 98 (15):1548-55
    View PubMed
  356. Jovanovic A, Jovanovic S, Carrasco AJ, Terzic A. Acquired resistance of a mammalian cell line to hypoxia-reoxygenation through cotransfection of Kir6.2 and SUR1 clones. Lab Invest. 1998 Sep; 78: (9)1101-7.
    View PubMed
  357. Dzeja PP, Terzic A. Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels. FASEB J. 1998 May; 12 (7):523-9
    View PubMed
  358. Brady PA, Terzic A. The sulfonylurea controversy: more questions from the heart. J Am Coll Cardiol. 1998 Apr; 31 (5):950-6
    View PubMed
  359. Lorenz E, Alekseev AE, Krapivinsky GB, Carrasco AJ, Clapham DE, Terzic A. Evidence for direct physical association between a K+ channel (Kir6.2) and an ATP-binding cassette protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K+ channel. Mol Cell Biol. 1998 Mar; 18 (3):1652-9
    View PubMed
  360. Jovanovic A, Jovanovic S, Mays DC, Lipsky JJ, Terzic A. Diadenosine 5',5"-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heart. FEBS Lett. 1998 Feb 27; 423 (3):314-8
    View PubMed
  361. Brady PA, Alekseev AE, Terzic A. Operative condition-dependent response of cardiac ATP-sensitive K+ channels toward sulfonylureas. Circ Res. 1998 Feb 9; 82 (2):272-8
    View PubMed
  362. Alekseev AE, Brady PA, Terzic A. Ligand-insensitive state of cardiac ATP-sensitive K+ channels. Basis for channel opening. J Gen Physiol. 1998 Feb; 111 (2):381-94
    View PubMed
  363. Jovanovic A, Lopez JR, Alekseev AE, Shen WK, Terzic A. Adenosine prevents K+-induced Ca2+ loading: insight into cardioprotection during cardioplegia. Ann Thorac Surg. 1998 Feb; 65 (2):586-91
    View PubMed
  364. Jovanovic A, Jovanovic S, Terzic A. Emerging therapeutic strategies in myocardial preservation: Focus on ATP-sensitive K+ Channels Emerg Ther Targ. 1998; 2:1-13, 1998.
  365. Lopez JR, Linares N, Brady PA, Terzic A. Cardiac hypertrophy determines digitalis action on intracellular Ca2+ in human myocardium. Eur J Pharmacol. 1997 Nov 27; 339(2-3):161-4.
    View PubMed
  366. Alekseev AE, Kennedy ME, Navarro B, Terzic A. Burst kinetics of co-expressed Kir6.2/SUR1 clones: comparison of recombinant with native ATP-sensitive K+ channel behavior. J Membr Biol. 1997 Sep 15; 159 (2):161-8
    View PubMed
  367. Jovanovic A, Alekseev AE, Terzic A. Intracellular diadenosine polyphosphates: a novel family of inhibitory ligands of the ATP-sensitive K+ channel. Biochem Pharmacol. 1997 Jul 15; 54 (2):219-25
    View PubMed
  368. Alekseev AE, Gomez LA, Aleksandrova LA, Brady PA, Terzic A. Opening of cardiac sarcolemmal KATP channels by dinitrophenol separate from metabolic inhibition. J Membr Biol. 1997 May 15; 157 (2):203-14
    View PubMed
  369. Gomez LA, Alekseev AE, Aleksandrova LA, Brady PA, Terzic A. Use of the MTT assay in adult ventricular cardiomyocytes to assess viability: effects of adenosine and potassium on cellular survival. J Mol Cell Cardiol. 1997 Apr; 29: (4)1255-66.
    View PubMed
  370. Shen WK, Terzic A, Stanton MS. Triggered activity and arrhythmogenesis: a clinical update. ACC Current Journal Review. 1997; 6(4):16-19.
  371. Jovanovic A, Alekseev AE, Lopez JR, Shen WK, Terzic A. Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg. 1997 Jan; 63 (1):153-61
    View PubMed
  372. Parkinson S, Alekseev AE, Gomez LA, Wagner F, Terzic A, Waldman SA. Interruption of Escherichia coli heat-stable enterotoxin-induced guanylyl cyclase signaling and associated chloride current in human intestinal cells by 2-chloroadenosine. J Biol Chem. 1997; 272:754-758.
    View PubMed
  373. Elvir-Mairena JR, Jovanovic A, Gomez LA, Alekseev AE, Terzic A. Reversal of the ATP-liganded state of ATP-sensitive K+ channels by adenylate kinase activity. J Biol Chem. 1996 Dec 13; 271 (50):31903-8
    View PubMed
  374. Brady PA, Alekseev AE, Aleksandrova LA, Gomez LA, Terzic A. A disrupter of actin microfilaments impairs sulfonylurea-inhibitory gating of cardiac KATP channels. Am J Physiol. 1996 Dec; 271 (6 Pt 2):H2710-6
    View PubMed
  375. Lopez JR, Jahangir R, Jahangir A, Shen WK, Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg. 1996 Sep; 112: (3)820-31.
    View PubMed
  376. Brady PA, Zhang S, Lopez JR, Jovanovic A, Alekseev AE, Terzic A. Dual effect of glyburide, an antagonist of KATP channels, on metabolic inhibition-induced Ca2+ loading in cardiomyocytes. Eur J Pharmacol. 1996 Jul 25; 308 (3):343-9
    View PubMed
  377. Alekseev AE, Jovanovic A, Lopez JR, Terzic A. Adenosine slows the rate of K(+)-induced membrane depolarization in ventricular cardiomyocytes: possible implication in hyperkalemic cardioplegia. J Mol Cell Cardiol. 1996 Jun; 28(6):1193-202.
    View PubMed
  378. Terzic A, Kurachi Y. Actin microfilament disrupters enhance K(ATP) channel opening in patches from guinea-pig cardiomyocytes. J Physiol. 1996 Apr 15; 492 ( Pt 2):395-404
    View PubMed
  379. Lopez JR, Ghanbari RA, Terzic A. A KATP channel opener protects cardiomyocytes from Ca2+ waves: a laser confocal microscopy study. Am J Physiol. 1996 Apr; 270 (4 Pt 2):H1384-9
    View PubMed
  380. Jovanovic A, Zhang S, Alekseev AE, Terzic A. Diadenosine polyphosphate-induced inhibition of cardiac KATP channels: operative state-dependent regulation by a nucleoside diphosphate. Pflugers Arch. 1996 Mar; 431 (5):800-2
    View PubMed
  381. Jovanovic A, Lopez JR, Terzic A. Cytosolic Ca2+ domain-dependent protective action of adenosine in cardiomyocytes. Eur J Pharmacol. 1996 Feb 29; 298 (1):63-9
    View PubMed
  382. Alekseev AE, Markevich NI, Korystova AF, Terzic A, Kokoz YM. Comparative analysis of the kinetic characteristics of L-type calcium channels in cardiac cells of hibernators. Biophys J. 1996 Feb; 70(2):786-97.
    View PubMed
  383. Jovanovic A, Terzic A. Diadenosine tetraphosphate-induced inhibition of ATP-sensitive K+ channels in patches excised from ventricular myocytes. Br J Pharmacol. 1996 Jan; 117 (2):233-5
    View PubMed
  384. Jovanovic A, Alekseev AE, Terzic A. Cardiac ATP-sensitive K+ channel: a target for diadenosine 5',5''-P1,P5-pentaphosphate. Naunyn Schmiedebergs Arch Pharmacol. 1996 Jan; 353 (2):241-4
    View PubMed
  385. Lopez JR, Terzic A. Inositol 1,4,5-trisphosphate induced Ca2+ release is regulated by cytosolic Ca2+ in intact skeletal muscle Pflugers Archiv Eur J Physiol 432, 782-79,. 1996; 0: 0.
  386. Jovanovic A, Terzic A. Diadenosine-hexaphosphate is an inhibitory ligand of myocardial ATP-sensitive K+ channels. Eur J Pharmacol. 1995 Nov 3; 286 (1):R1-2
    View PubMed
  387. Lopez JR, Perez C, Linares N, Allen P, Terzic A. Hypersensitive response of malignant hyperthermia-susceptible skeletal muscle to inositol 1,4,5-triphosphate induced release of calcium. Naunyn Schmiedebergs Arch Pharmacol. 1995 Oct; 352(4):442-6.
    View PubMed
  388. Lopez JR, Jovanovic A, Terzic A. Spontaneous calcium waves without contraction in cardiac myocytes. Biochem Biophys Res Commun. 1995 Sep 25; 214: (3)781-7.
    View PubMed
  389. Terzic A, Jahangir A, Kurachi Y. Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs. Am J Physiol. 1995 Sep; 269 (3 Pt 1):C525-45
    View PubMed
  390. Lopez JR, Linares N, Cordovez G, Terzic A. Elevated myoplasmic calcium in exercise-induced equine rhabdomyolysis. Pflugers Arch. 1995 Jun; 430(2):293-5.
    View PubMed
  391. Lopez JR, Rojas B, Gonzalez MA, Terzic A. Myoplasmic ca sup 2+ concentration during exertional rhabdomyolysis. Lancet. 1995 Feb 18; 345(8947):424-5.
    View PubMed
  392. Terzic A, Tung RT, Kurachi Y. Nucleotide regulation of ATP sensitive potassium channels. Cardiovasc Res. 1994 Jun; 28 (6):746-53
    View PubMed
  393. Jahangir A, Terzic A, Kurachi Y. Intracellular acidification and ADP enhance nicorandil induction of ATP sensitive potassium channel current in cardiomyocytes. Cardiovasc Res. 1994 Jun; 28 (6):831-5
    View PubMed
  394. Terzic A, Findlay I, Hosoya Y, Kurachi Y. Dualistic behavior of ATP-sensitive K+ channels toward intracellular nucleoside diphosphates. Neuron. 1994 May; 12 (5):1049-58
    View PubMed
  395. Terzic A, Tung RT, Inanobe A, Katada T, Kurachi Y. G proteins activate ATP-sensitive K+ channels by antagonizing ATP-dependent gating. Neuron. 1994 Apr; 12 (4):885-93
    View PubMed
  396. Terzic A, Jahangir A, Kurachi Y. HOE-234, a second generation K+ channel opener, antagonizes the ATP-dependent gating of cardiac ATP-sensitive K+ channels. J Pharmacol Exp Ther. 1994 Feb; 268(2):818-25.
    View PubMed
  397. Yamada M, Terzic A, Kurachi Y. Regulation of K+ Channels by G Protein Subunits and arachidonic acid metabolites Meth Enzymol 238, 394-422,. 1994; 0: 0.
  398. Yamada M, Terzic A, Findlay I, Jahangir A, Shen WK, Kurachi Y. YM934, a novel K+ channel opener, activates ATP-sensitive K+ channels in cardiac myocytes. J Pharmacol Exp Ther. 1993 Dec; 267(3):1544-9.
    View PubMed
  399. Terzic A, Tung RT, Shen WK, Yamada M, Kurachi Y. Cardiovascular profile of E4080 and its analogue er001533: novel potassium channel openers with bradycardic properties. Cardiovasc Drug Rev. 1993 Summer; 11:223-233.
  400. Puceat M, Clement-Chomienne O, Terzic A, Vassort G. Alpha 1-Adrenoceptor and purinoceptor agonists modulate the Na/H antiport in single cardiac cells Am J Physiol 264, H31-H319,. 1993; 0: 0.
  401. Terzic A, Puceat M, Vassort G, Vogel SM. Cardiac alpha 1-adrenoceptors: An overview Pharmacol Rev 45, 147-175,. 1993; 0: 0.
  402. Terzic A, Puceat M, Clement-Chomienne O, Vassort G. Phenylephrine and ATP enhance an amiloride insensitive bicarbonate-dependent alkalinizing mechanism in rat single cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol. 1992 Nov; 346 (5):597-600
    View PubMed
  403. Terzic A, Puceat M, Clement O, Scamps F, Vassort G. Alpha 1-Adrenergic effects on intracellular pH and calcium, and on myofilaments in single rat cardiac cells. J Physiol Lond. 1992; 447, 275-92.
  404. Puceat M, Terzic A, Clement O, Scamps F, Vogel SM, Vassort G. Cardiac alpha 1-adrenoceptors mediate positive inotropy via myofibrillar sensitization Trends in Pharmacol Sci 13, 263-265,. 1992; 0: 0.
  405. Terzic A, Puceat O, Clement-Chomienne O, Vassort G. Phenylephrine and ATP enhance a bicarbonate-dependent alkalinizing mechanism in rat ventricular single cardiac cells Naunyn-Schmiedebergs Arch Pharmacol 346, 597-60,. 1992; 0: 0.
  406. Terzic A, Vogel S. On the mechanism of the positive inotropic action of the alpha-adrenoceptor agonist, phenylephrine, in rat left atria J Pharmacol Exp Ther 257, 52-529,. 1991; 0: 0.
  407. Terzic A, Anagnostopoulos T, Vogel S. Opposite modulation of ouabain cardiotoxicity by hexamethyleneamiloride and phenylephrine Naunyn-Schmiedeberg's Arch Pharmacol 343, 511-518,. 1991; 0: 0.
  408. Terzic A, Vogel S. Amiloride-sensitive actions of an alpha-adrenoceptor agonist and ouabain in rat atria J Mol Cell Cardiol 22, 391-42,. 1990; 0: 0.
  409. Vogel S, Terzic A. Alpha-adrenergic regulation of action potentials in isolated rat cardiomyocytes. Eur J Pharmacol 164, 231-239,. 1989; 0: 0.
  410. Terzic A, Japundzic N. The emetic effect of dopamine Med Podml 39, 11-16,. 1987; 0: 0.
  411. Cemerikic D, Terzic A. Intracellular potential and K+ and Na+ activities in triturus kidney proximal tubular cells. Iugoslav Physiol Pharmacol Acta 21, 227-238,. 1985; 0: 0.
  412. Beleslin D, Jovanovic-Micic D, Japundzic N, Terzic A, Samardzic R. Behavioral, autonomic and motor effects of neuroleptic drugs in cat: Motor impairment and aggression. Brain Res Bull 15, 353-356,. 1985; 0: 0.
  413. Milovanovic S, Urbancic M, Terzic A. The experimental model of isolated, double perfused frog kidney (Rana esculenta). Med Podml 37, 141-144,. 1985; 0: 0.
  414. Beleslin D, Jovanovic-Micic D, Japundzic N, Terzic A. Gross behavioral effects of adrenergic blocking agents in cats Period Biol 87, 22-204,. 1985; 0: 0.
  415. Terzic A, Urbancic M. The influence of the drugs' priority list on the drug consumption in hopsitals. Med Podml. 1984; 36:177-82.
PST-20221477